213800NW5GVIRMXSRL482023-02-012024-01-31iso4217:GBP213800NW5GVIRMXSRL482022-02-012023-01-31iso4217:GBPxbrli:shares213800NW5GVIRMXSRL482024-01-31213800NW5GVIRMXSRL482023-01-31213800NW5GVIRMXSRL482022-01-31ifrs-full:IssuedCapitalMember213800NW5GVIRMXSRL482022-01-31ifrs-full:SharePremiumMember213800NW5GVIRMXSRL482022-01-31ifrs-full:ReserveOfSharebasedPaymentsMember213800NW5GVIRMXSRL482022-01-31ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember213800NW5GVIRMXSRL482022-01-31ifrs-full:RetainedEarningsMember213800NW5GVIRMXSRL482022-01-31213800NW5GVIRMXSRL482022-02-012023-01-31ifrs-full:IssuedCapitalMember213800NW5GVIRMXSRL482022-02-012023-01-31ifrs-full:SharePremiumMember213800NW5GVIRMXSRL482022-02-012023-01-31ifrs-full:ReserveOfSharebasedPaymentsMember213800NW5GVIRMXSRL482022-02-012023-01-31ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember213800NW5GVIRMXSRL482022-02-012023-01-31ifrs-full:RetainedEarningsMember213800NW5GVIRMXSRL482023-01-31ifrs-full:IssuedCapitalMember213800NW5GVIRMXSRL482023-01-31ifrs-full:SharePremiumMember213800NW5GVIRMXSRL482023-01-31ifrs-full:ReserveOfSharebasedPaymentsMember213800NW5GVIRMXSRL482023-01-31ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember213800NW5GVIRMXSRL482023-01-31ifrs-full:RetainedEarningsMember213800NW5GVIRMXSRL482023-02-012024-01-31ifrs-full:IssuedCapitalMember213800NW5GVIRMXSRL482023-02-012024-01-31ifrs-full:SharePremiumMember213800NW5GVIRMXSRL482023-02-012024-01-31ifrs-full:ReserveOfSharebasedPaymentsMember213800NW5GVIRMXSRL482023-02-012024-01-31ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember213800NW5GVIRMXSRL482023-02-012024-01-31ifrs-full:RetainedEarningsMember213800NW5GVIRMXSRL482024-01-31ifrs-full:IssuedCapitalMember213800NW5GVIRMXSRL482024-01-31ifrs-full:SharePremiumMember213800NW5GVIRMXSRL482024-01-31ifrs-full:ReserveOfSharebasedPaymentsMember213800NW5GVIRMXSRL482024-01-31ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember213800NW5GVIRMXSRL482024-01-31ifrs-full:RetainedEarningsMember
Alkemy Capital Investments plc
Annual Report
for the Year ended 31 January 2024
ALKEMY CAPITAL INVESTMENTS PLC
Annual Report for the period ended 31 January 2024
2
Table of contents
Company Information .............................................................................................................................. 3
Chairman’s Statement ............................................................................................................................. 4
Strategic Report ...................................................................................................................................... 7
Board of Directors .................................................................................................................................. 11
Directors’ Report .................................................................................................................................... 12
Directors’ Remuneration Report ............................................................................................................ 15
Risk Management Report ...................................................................................................................... 20
Directors’ Responsibility Statement ....................................................................................................... 25
Consolidated Statement of Comprehensive Income ............................................................................. 31
Consolidated Statement of Financial Position ....................................................................................... 32
Consolidated Statement of Changes in Equity ...................................................................................... 33
Consolidated Statement of Cash Flows ................................................................................................ 34
Company Statement of Financial Position ............................................................................................ 35
Company Statement of Changes in Equity ........................................................................................... 36
Company Statement of Cash Flows ...................................................................................................... 37
Notes to the Financial Statements......................................................................................................... 38
3
Company Information
Directors
Paul Atherley Non-Executive Chairman
Sam Quinn Non-Executive Director
Helen Pein Non-Executive Director
Vikki Jeckell (Appointed 20 November 2023) Non-Executive Director
Company Number
13149164
Company Secretary
Sam Quinn, Silvertree Partners LLP
Registered address
167-169 Great Portland Street
Fifth Floor
London
England
W1W 5PF
Independent auditors
Crowe U.K. LLP
55 Ludgate Hill
London
EC4M 7JW
Company solicitors (UK)
Simmons & Simmons LLP
1 Ropemaker Street
London
EC2Y 9SS
Registrars
Neville Registrars
Neville House
Steelpark Road
Halesowen
B62 8HD
Company Website
www.alkemycapital.co.uk
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
4
Chairman’s Statement
I have great pleasure in presenting our Annual Report for the year ended 31 January 2024.
Alkemy Capital Investments plc (“Alkemy”) was formed to invest in the critical minerals sector. As a holding
company our aim is to foster the growth and expansion of our subsidiaries, steering them towards operational
excellence and sustainable practices.
Our strategy is to finance the development of the individual businesses at the asset level through project related
debt, and institutional equity or strategic partnerships.
Alkemy currently has three investments, excluding the service entity ACSA, namely:
• Tees Valley Lithium Limited (“TVL”) which is actively developing the UK’s first Lithium Hydroxide
processing facility at Wilton International in Teesside, UK;
• Tees Valley Graphite Limited (“TVG”) which is seeking in partnership with Syrah Resources to develop
a commercial scale natural graphite active anode material processing facility, also at Wilton
International; and
• Port Hedland Lithium Pty Ltd (“PHL”) which is potentially developing a lithium sulphate refinery in Port
Hedland, Western Australia.
TVL, our most advanced project, has received planning and environmental permissions for the production of up
to 96,000 tonnes per annum of battery grade lithium hydroxide to supply key UK and international customers.
We have entered into feedstock and offtake arrangements with major partners and established other key
strategic partnerships and have worked closely with government and regulatory bodies, reflecting our
commitment to becoming a leader in the low-carbon production of battery-grade lithium chemicals.
The success of these strategic initiatives and partnerships will place TVL at the forefront of Europe’s lithium
refining sector, and we are looking to replicate this success across other key critical battery minerals, including
graphite, with a view to developing a multi-minerals strategy.
Despite recent market shifts, European demand for lithium remains on an upward trajectory. With the UK and
EU’s transition towards electric vehicles (EVs), there’s a forecasted demand for lithium that far exceeds current
supply capacity. The UK and European Commission’s move to ban combustion engine cars by 2035 is a
significant catalyst, signalling a shift towards a more sustainable and electric future. This policy change, along
with similar initiatives worldwide, is expected to fuel a consistent and growing demand for lithium.
As Europe’s car makers make the switch to EVs to meet this burgeoning demand there is over 700GW of
gigafactory capacity either in construction or planned to provide the batteries for these EVs.
These gigafactories will require over 650,000 tonnes of locally refined lithium per year in the form of either
hydroxide or carbonate depending on the type of vehicle. Currently the UK and Europe has limited lithium
refining capacity. Building a European lithium processing facility will reduce the regional dependence on China,
which currently controls 90% of the world’s lithium refining capacity.
Recognising the escalating demand for lithium, Alkemy has been actively developing its lithium refining portfolio
through TVL and PHL. Alkemy’s focus is not just on meeting the immediate market needs but on establishing
a supply chain that is resilient, environmentally responsible, and capable of adapting to the rapidly evolving
energy landscape.
Tees Valley Lithium
TVL is currently developing a lithium hydroxide monohydrate (“LHM”) refinery at the Wilton International
Chemicals Park in Teesside, UK.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
5
Since its inception, TVL has achieved a number of key milestones and in late 2023 reached an agreement in
principle with Wogen Resources Limited to supply up to 20,000 tonnes of technical grade lithium carbonate
feedstock per annum for an initial period of five years. The supply will be sufficient to fill the first of the proposed
four trains at Wilton producing around 24,000 tonnes of battery grade lithium hydroxide or lithium carbonate
equivalent.
Wogen is a leading international trader of off-exchange specialty metals and minerals, with a long history and
well-established presence in the battery metals market across Asia, the United States and Europe. Wogen has
an active trading book in lithium products procuring from an array of producing countries and selling into the
battery supply chain.
In late 2023 Alkemy and TVL appointed to their respective Board of Directors battery metals supply chain expert
Vikki Jeckell. Vikki’s appointment comes at a crucial time for Alkemy as it embarks on its ambitious growth plans
in the rapidly evolving battery materials sector. Vikki brings a wealth of experience and expertise in supply chain
management, particularly within the battery materials industry. Her extensive background includes five years at
Johnson Matthey as Head of Supply Chain Strategy for Battery Materials.
TVL, also in late 2023, awarded preferred vendor status to industry leaders Jord Proxa and Eurodia Industrie
SAS. The completion of the technology selection process and the awarding of preferred vendor status to these
two industry leaders is an important step forward in the project’s development.
TVL is currently in advanced discussions with a number of offtake customers, including European gigafactories
and electric vehicle original equipment manufacturers (OEMs). These customers are increasingly focussed on
price, transparency and low embedded carbon, when sourcing high grade lithium products.
By sourcing low carbon feedstock and powering an electrochemical refining process with offshore wind, TVL
aims to supply its UK and European customers with the world’s lowest-carbon lithium hydroxide.
TVL is currently in discussions with a number of leading financial institutions for the financing of its Wilton
refinery. The US$300m approximate capital cost of train 1 is expected to be financed largely through green
bonds (for which TVL will seek accreditation) combined with a mix of debt, strategic equity finance and grant
funding, all at project level.
Having secured feedstock for its first train at Wilton, a key component for these financing discussions, TVL is in
discussions with leading financial institutions and strategic partners to obtain project-level funding that will
enable it to complete Front End Engineering Design (FEED) and reach a final investment decision for the bond
finance. TVL continues to make steady progress in these discussions and will update the market as soon as
this key piece of funding is secured.
Port Hedland Lithium
In 2022, Alkemy announced the launch of its strategy to build a lithium sulphate monohydrate (“LSM”) refinery
in Port Hedland, Australia, to serve as a refining hub for Australian spodumene producers. PHL has secured an
allocation of land at the new Boodarie Strategic Industrial Area, alongside other global leaders in the green
industrial sector, to facilitate the development of the Port Hedland LSM refinery.
In August 2023, PHL announced the completion of a Class 4 Feasibility Study for its LSM refinery, each train of
which will process spodumene concentrate to produce 40,000 tonnes of lithium sulphate annually. In addition,
a Flora and Fauna baseline survey was completed as part of the required environmental approvals. PHL will
continue to develop its LSM refinery, either standalone or in conjunction with strategic partners, several of whom
it is currently in discussions with.
Building the Port Hedland LSM refinery will provide Australian spodumene producers with a complete mid-
stream lithium refining solution with direct access to the European market through TVL’s LHM refinery in
Teesside, UK. Importantly, the Port Hedland LSM refinery will bring major value-adding to the Pilbara region,
with significant multiplier benefits for the local community and the State of Western Australia, whilst reducing
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
6
the carbon footprint of the end-to-end lithium battery cell supply chain to meet new European emissions
standards.
Tees Valley Graphite
In January 2024, Alkemy announced the launch of TVG and that TVG had entered into a non-binding
memorandum of understanding (MOU) with Syrah Resources (SYR:ASX) (“Syrah”) for the establishment of a
joint venture to develop a commercial-scale natural graphite active anode material (“AAM”) processing facility
(“Wilton AAM facility”) located at the Wilton International Chemicals Park in Teesside, UK.
Syrah and TVG are currently negotiating a binding joint venture agreement and will each initially have a 50%
interest in the joint venture. The Wilton AAM facility is proposed to be supplied with natural graphite from Syrah’s
Balama graphite project in Mozambique, the world’s largest integrated graphite operation.
The joint venture will combine Syrah’s global graphite development, operations and sales expertise with
Alkemy’s UK development capabilities at the plug-and-play Wilton International Chemicals Park, benefitting
from well-established infrastructure, essential utilities, and the Teesside Freeport.
The joint venture will target an initial production capacity of 20,000 tonnes AAM per annum for supply into cell
manufacturers and OEMs located in the UK and European battery markets. The Wilton AAM facility is expected
to gain access to low-carbon offshore wind power providing 100% certified green low-cost energy enabling it to
produce a low carbon product.
The Wilton AAM facility will leverage the successful planning and approvals and local knowledge gained by
Alkemy portfolio company TVL and will aim to lower construction costs, project delivery timeframes and bring
forward first production by replicating and upscaling the technology and design used at Syrah’s Vidalia AAM
facility in Louisiana, United States.
Syrah is a leading ex-China supplier of quality graphite products and has significant practical knowledge and
know-how in the development of an AAM processing facility, including in feasibility, detailed design and
engineering, process technologies, equipment selection and procurement, construction management and
product development, product qualification and offtakes.
Syrah and TVG intend to enter into a binding joint venture agreement, which will govern feasibility and permitting
workplans and schedules, budget and relevant milestones associated with the Wilton AAM Facility. Ultimately,
development of the Wilton AAM facility is planned to be subject to a final investment decision being unanimously
approved by Syrah and TVG following the completion of further technical studies, receipt of approvals, entry
into a shareholders’ agreement, incorporation of a project company, and financing and offtake commitments.
Syrah and TVG will each initially have a 50% interest in the joint venture.
The Wilton AAM facility is expected to be financed at project level through green bonds (for which accreditation
shall be sought), combined with a mix of debt, strategic equity finance and grant funding (via domestic and
accessible international grant funding programmes).
In conclusion, I would like to take this opportunity to thank our shareholders for their continued support and look
forward to reporting on our progress during the course of 2024.
Paul Atherley
Non-Executive Chairman
30 May 2024
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
7
Strategic Report
The Directors present the Strategic Report of the Group for the year ended 31 January 2024.
Review of business and future developments
The Company was incorporated and registered in England and Wales on 21 January 2021 and on 27 September
2021 was admitted to the Standard Listing segment of the Official List of the UK Listing Authority and to trading
on the London Stock Exchange.
The Company was formed to undertake an Acquisition of a controlling interest in a company or business. Given
their experience, the Board focused on the mining and technology metals sectors.
On 25 February 2022, the Group announced that it had entered into an exclusivity agreement (the “Exclusivity
Agreement”) with Sembcorp Utilities (UK) Limited and a heads of terms in respect of a proposed option to enter
into a lease over a brownfields site (the “Site”) at Wilton International (the “Agreement to Lease”) and a long
lease over the Site. Wilton International is a well-established chemical engineering park located in Teesside, a
major Freeport in the UK. The entering into the Exclusivity Agreement and incorporation of TVL constituted an
Acquisition and reverse takeover transaction under the rules of the London Stock Exchange.
On 19 December 2022 the Group announced that it had entered into the Agreement to Lease pursuant to which
an agreed form lease may be entered into by TVL, a subsidiary of the Company, following the completion of
certain conditions precedent under the Agreement to Lease (the “Lease”). It is intended that TVL will be the
operating company that develops the Project.
If the Board determines that the opportunities presented by the development of the Site would be in the best
interests of shareholders, the Group, via TVL, intends to enter into the Lease and to commence the design,
finance and construct of a plant that will produce lithium hydroxide monohydrate from lithium sulphate or
carbonate feedstock with a view to becoming a key supplier to the UK and European battery cell manufacturers
(the “Project”).
The principal activity of the Company is to act as the holding company to TVL, an operating subsidiary, which
will enter into the Lease. The Company will provide a parent company guarantee to Sembcorp in order to
guarantee the operating subsidiary’s obligations under the Lease. The Company aims to implement an
operating strategy with a view to generating value for its shareholders through the creation of a lithium hydroxide
monohydrate facility.
Key developments for the Group during the course of the financial year included the following:
• In August 2023, PHL announced the completion of a Class 4 Feasibility Study for its LSM refinery, each
train of which will process spodumene concentrate to produce 40,000 tonnes of lithium sulphate
annually. In addition, a Flora and Fauna baseline survey was completed as part of the required
environmental approvals.
• In late 2023 the Company reached an agreement in principle with leading international trader Wogen
Resources Limited to supply up to 20,000 tonnes of technical grade lithium carbonate feedstock per
annum for TVL’s LHM refinery for an initial period of five years. The supply will be sufficient to fill the
first of the proposed four trains at Wilton producing around 24,000 tonnes of battery grade lithium
hydroxide or lithium carbonate equivalent.
• In late 2023 Alkemy and TVL appointed to their respective Board of Directors, battery metals supply
chain expert Vikki Jeckell. Vikki’s extensive background includes five years at Johnson Matthey as
Head of Supply Chain Strategy for Battery Materials.
• TVL, also in late 2023, awarded preferred vendor status to industry leaders Jord Proxa and Eurodia
Industrie SAS. The completion of the technology selection process and the awarding of preferred
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
8
vendor status to these two industry leaders is an important step forward in the development of TVL’s
LHM refinery.
• In January 2024, Alkemy announced the launch of TVG and that TVG had entered into a non-binding
MOU with Syrah Resources for the establishment of a joint venture to develop a commercial-scale
natural graphite and active anode material (AAM) processing facility located at the Wilton International
Chemicals Park in Teesside, UK.
• In February 2024 the Company announced the appointment of Zeus Capital as Financial Adviser and
Corporate Broker.
Alkemy was formed to invest in the critical minerals sector. As a holding company its strategy is to foster the
growth and expansion of its subsidiaries, steering them towards operational excellence and sustainable
practices and to finance the development of these individual businesses at the asset level through project
related debt, and institutional equity or strategic partnerships.
TVL is currently in discussions with a number of leading financial institutions for the financing of its Wilton
refinery. The US$300m approximate capital cost of train 1 is expected to be financed largely through green
bonds (for which TVL will seek accreditation) combined with a mix of debt, strategic equity finance and grant
funding, all at project level.
Having secured feedstock for its first train at Wilton, a key component for these financing discussions, TVL’s
primary short term focus is to consummate discussions with leading financial institutions and strategic partners
to obtain project-level funding that will enable it to complete Front End Engineering Design and reach a final
investment decision for the bond finance.
Key performance indicators
When the Group enters into the Lease, financial, operational, health, safety, and environmental KPIs will
become more relevant and reported upon as appropriate. As a result, the Directors are of the opinion that
analysis using KPI’s is not appropriate for an understanding of the business at this time.
Principal risks and uncertainties
The principal risks and uncertainties currently faced by the Group are set out further in the Risk Management
Report on page 18.
Gender analysis
A split of the Directors, senior managers and employees by gender at the end of the financial year is as follows:
Male – 2 (directors)
Female – 2 (directors)
The Group recognises the need to operate a gender diverse business. The Board will also ensure any future
employment takes into account the necessary diversity requirements and compliance with all employment law.
The Board has experience and sufficient training and qualifications in dealing with such issues to ensure they
would meet all requirements. More detail will be disclosed in the future annual reports once the Company enters
into the Lease and has completed its transition to an operating company.
Corporate social responsibility
The Group aims to conduct its business with honesty, integrity and openness, respecting human rights and the
interests of shareholders and employees. The Group aims to provide timely, regular and reliable information on
the business to all its shareholders and conduct its operations to the highest standards.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
9
The Group strives to create a safe and healthy working environment for the wellbeing of its staff and to create
a trusting and respectful environment, where all members of staff are encouraged to feel responsible for the
reputation and performance of the Group.
The Group aims to establish a diverse and dynamic workforce with team players who have the experience and
knowledge of the business operations and markets in which we operate. Through maintaining good
communications, members of staff are encouraged to realise the objectives of the Group and their own potential.
Corporate environmental responsibility
This will become more relevant once the Company enters into the Lease and completes its transition to an
operating company. The Board contains personnel with a good history of running businesses that have been
compliant with all relevant laws and regulations and there have been no instances of non-compliance in respect
of environment matters.
The Group’s policy is to minimize the risk of any adverse effect on the environment associated with its activities
with a thoughtful consideration of key areas such as energy use, pollution, transport, renewable resources,
health and wellbeing. The Group also aims to ensure that its suppliers and advisers meet with their legislative
and regulatory requirements and that codes of best practice are met.
Section 172(1) Statement – Promotion of the Group for the benefit of the members as a whole
The Directors believe they have acted in the way most likely to promote the success of the Group for the benefit
of its members as a whole, as required by s172 of the Companies Act 2006.
The requirements of s172 are for the Directors to:
1. Consider the likely consequences of any decision in the long term,
2. Act fairly between the members of the Group,
3. Maintain a reputation for high standards of business conduct,
4. Consider the interests of the Group’s employees,
5. Foster the Group’s relationships with suppliers, customers and others, and
6. Consider the impact of the Group’s operations on the community and the environment.
The pre-revenue nature of the business is important to the understanding of the Group by its members,
employees and suppliers, and the Directors are as transparent about the cash position and funding
requirements as is allowed under LSE regulations.
The application of the s172 requirements can be demonstrated in relation to the some of the key decisions
made during 2023 and after the year end:
• The completion by PHL of a Class 4 Feasibility Study for its LSM refinery
• The execution of an agreement in principle with leading international trader Wogen Resources Limited
to supply up to 20,000 tonnes of technical grade lithium carbonate feedstock per annum to TVL for an
initial period of five years
• The appointment of battery metals supply chain expert Vikki Jeckell to the boards of Alkemy and TVL
• The awarding of preferred vendor status to industry leaders Jord Proxa and Eurodia Industrie SAS
• The launch of TVG and the signing of a non-binding MOU with industry leader Syrah Resources for
the establishment of a joint venture to develop a commercial-scale natural graphite AAM processing
facility
• The appointment of Zeus Capital Limited as financial adviser and broker
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
10
The Board takes seriously its corporate social responsibilities to the environment in which it works which will
become more relevant once the Company enters into the Lease and completes its transition to an operating
company.
Paul Atherley
Non-Executive Chairman
30 May 2024
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
11
Board of Directors
Paul Atherley – Non-Executive Chairman
Paul Atherley is a highly experienced senior resources executive with wide ranging international and capital
markets experience. He graduated as mining engineer from Imperial College London and has held a number of
senior executive and board positions. Paul is currently Chairman of LSE listed Pensana Plc which is establishing
the world’s first independent and sustainable rare earth processing facility in the UK.
Paul is based in London and has broad experience in raising debt and equity finance for resource companies.
He served as Executive Director of the investment banking arm of HSBC Australia where he undertook a range
of advisory roles in the resources sector. He has completed a number of acquisitions and financings of
resources projects in Europe, China, Australia and Asia.
Paul is a strong supporter of Women in STEM and has established a scholarship which provides funding for
young women to further their education in science and engineering.
Sam Quinn – Non-Executive Director
Sam Quinn is a corporate lawyer with over fifteen years’ worth of experience in the natural resources sector, in
both legal counsel and management positions. Sam is a principal of Silvertree Partners, a London-based
specialist corporate services provider for the natural resources industry. In addition Sam holds various other
Non-Executive Directorships and company secretarial roles for listed and unlisted natural resources companies.
During time spent in these roles, Sam has gained significant experience in the administration, operation,
financing and promotion of natural resource companies.
Previously, Sam worked as the Director of Corporate Finance and Legal Counsel for the Dragon Group, a
London based natural resources venture capital firm and as a corporate lawyer for Jackson McDonald Barristers
& Solicitors in Perth, Western Australia and for Nabarro LLP in London.
Helen Pein – Non-Executive Director
Helen Pein has over 30 years’ experience in the natural resources sector and currently serves as a Director of
Pan Iberia Ltd, Trident Royalties Plc and Panex Resources Pty Ltd.
Helen was formerly a Director of Pangea Exploration Pty Ltd, a company affiliated with Denham Capital where
she was part of the team directly responsible for the discovery of a number of world-class gold and mineral
sands deposit across Africa. Helen is a recipient of the Gencor Geology Award.
Vikki Jeckell – Non-Executive Director
Vikki Jeckell, appointed 20 November 2023, is a strategic procurement and supply chain expert with over 15
years’ worth of experience in the sector and is the former the Head of Supply Chain Strategy Development &
Control for Battery Materials at Johnson Matthey. In this role Vikki, led transformative initiatives, including the
establishment of an industry-leading responsible sourcing program and the formation of strategic partnerships,
contributing substantially to the company's global supply chain capabilities.
Vikki has also worked as Head of Supply Chain Development for hydrogen company LIFTE H2, held a senior
leadership role at Women in Green Hydrogen and in 2022 she founded Supply Tactics Limited, a consultancy
firm dedicated to enhancing supply chain management within the batteries and hydrogen sectors.
Vikki has provided expert testimony to House of Commons committees on several occasions, reflecting her
commitment to help shaping policies within energy transition. Vikki holds an LLB and an MBA.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
12
Directors’ Report
The Directors present their annual report together with the financial statements and Auditor’s Report for the
year ended 31 January 2024. The following information is not presented in the Directors’ report as it is presented
in the Strategic Report in accordance with s414C(11); Review of business, Key Performance Indicators,
Principal risks and uncertainties, Gender analysis, Corporate social responsibility, Corporate environmental
responsibility, Section 172(1) statement.
Results and dividends
The results of the Group for the year ended 31 January 2024 are set out in the Statement of Comprehensive
Income on page 29. The Directors do not recommend the payment of a dividend for the year.
Directors and Directors’ interests
The Directors who served during the year to date are as follows:
Paul Atherley
Sam Quinn
Helen Pein
Vikki Jeckell (Appointed 20 November 2023)
The beneficial shareholdings of the Board in the Company as at 31 January 2024 were as follows:
Number of ordinary
shares
% of issued share
capital
Share options
P Atherley
3,313,714
37.59%
250,000
S Quinn
446,428
5.06%
215,000
H Pein
25,000
0.28%
75,000
V Jeckell
-
-
175,000
Director incentives
Details on Directors remuneration can be found in the Directors Remuneration report on page 15.
Substantial shareholders
As at the date of this Report, the total number of issued Ordinary Shares with voting rights in the Company was
8,814,851. The Company has been notified of the following interests of 3 per cent or more in its issued share
capital as at the date of this report.
Shareholder
% of issued
share capital
Paul Atherley
37.59%
Sam Quinn
5.06%
Corporate governance
The Group has set out its full Corporate Governance Statement on page 23. The Corporate Governance
Statement forms part of this Directors’ report and is incorporated into it by cross reference.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
13
Greenhouse gas disclosures
As the Group remains in the early stages of development without any current physical operations across its
portfolio of projects, it is not practical to obtain and analyse emissions data for the Group operations. However,
given the minor level of physical operations in the year, and the lack of any plant or office space, the carbon
footprint and climate change impact of the Group’s operations are considered to be negligible, and in any event
below the 40 MWh threshold prescribed for detailed emissions disclosures.
As such, the Group does not consider it relevant to provide climate related disclosures under the recently
enacted TCFD guidelines, nor would determination of the relevant emissions data be practical. Once the Group
has commenced the construction of physical premises across any of its projects, and hence transitioned into
an operating company, it will revisit its position on climate disclosures accordingly.
Supplier payment policy
The Group’s current policy concerning the payment of trade creditors is to follow the CBI’s Prompt Payers Code
(copies are available from the CBI, Centre Point, 103 New Oxford Street, London WC1A 1DU).
The Group’s current policy concerning the payment of trade creditors is to:
• settle the terms of payment with suppliers when agreeing the terms of each transaction;
• ensure that suppliers are made aware of the terms of payment by inclusion of the relevant terms in
contracts; and
• pay in accordance with the Group’s contractual and other legal obligations.
Financial instruments and risk management
The Group is exposed to a variety of financial risks and the impact on the Group’s financial instruments are
summarised in the Risk Management Report. Details of the Group’s financial instruments are disclosed in note
17 to the financial statements.
Directors’ insurance
The Group has implemented Directors and Officers Liability Indemnity Insurance.
Events after the reporting year
On 26 February 2024 the Group appointed Zeus Capital as financial advisor and broker.
Going concern
As part of their assessment of going concern, the Directors have prepared cash forecasts to determine the
funding requirements of the business over the 18 months from the reporting date. Cash requirements over this
period have been projected in the range of a £2m minimum (decelerated project development case) to £9m
maximum (accelerated project development case) depending on the level of technical project development work
being undertaken, as determined by funding availability.
As at the date of this report, the Directors are considering a variety of funding options from numerous parties to
consider the option best suited to balancing the immediate cash flow needs of the business and desire to
accelerate the project development timeframe against the need to avoid unnecessary dilution of the
shareholders during a period of depressed equity market prices. Options ranging from:
• project level debt or strategic equity which would provide sufficient funding to accelerate the project
development program over the period of consideration, including the Wilton LHM refinery train 1 FEED
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
14
study alongside development of the Port Hedland LSM refinery and TVG graphite projects, as well as
general working capital requirements;
• market equity placings to secure working capital funding needs whilst project development funding
opportunities continue to be assessed;
• convertible lending facilities which may act as a hybrid of working capital and project development
funding, allowing progression of project development at a less accelerated rate that would be the case
under a more substantial project lending facility;
• any combination of the above.
The Board remains in detailed discussions on the above funding opportunities and anticipates concluding this
process in the near term.
The Directors are therefore reasonably confident that the necessary funding will be secured, as and when
required, by executing on one of the above options under consideration, such that the Directors have a
reasonable expectation that the Group will continue in operational existence for the next 12 months. However
as successful execution of one of the above fundraising options cannot be assured, a material uncertainty exists
which may cast significant doubt on the ability of the company and group to continue as a going concern and
realise its assets and discharge its liabilities in the normal course of business.
Accordingly, the Directors believe that as at the date of this report it is appropriate to continue to adopt the going
concern basis in preparing the financial statements.
Disclosure of information to Auditor
The Directors confirm that:
• So far as each Director is aware, there is no relevant audit information of which the company’s auditor is
unaware; and
• The Directors have taken all steps that they ought to have taken as Directors in order to make themselves
aware of any relevant audit information and to establish that the auditor is aware of that information.
Auditor
A resolution proposing the re-appointment of Crowe U.K. LLP as auditor will be put to shareholders at the
Annual General Meeting.
This Directors’ Report has been approved by the Board and signed on its behalf by:
Paul Atherley
Non-Executive Chairman
30 May 2024
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
15
Directors’ Remuneration Report
Until the Lease is entered into and the Company completes its transition to an operating company, the Company
will not have a separate remuneration committee. The Board will instead periodically review the quantum of
Directors’ fees, taking into account the interests of shareholders and the performance of the Company and the
Directors.
The Directors who held office at 31 January 2024 are summarised as follows:
Name of Director
Position
P Atherley
Non-Executive Chairman
S Quinn
Non-Executive Director
H Pein
Non-Executive Director
V Jeckell
Non-Executive Director
Directors’ Letters of appointment
Letter of Appointment – Paul Atherley
Pursuant to a letter of appointment dated 21 September 2021 between the Company and Mr Atherley, Mr
Atherley is engaged as Chairman with fees of £24,000 per annum. The appointment can be terminated by either
party on three months written notice.
Letter of Appointment – Sam Quinn
Pursuant to a letter of appointment dated 21 September 2021 between the Company and Sam Quinn, Mr Quinn
is engaged as a Non-Executive Director with fees of £18,000 per annum. In addition Sam Quinn will be
remunerated for additional work performed for the Company which is outside the scope of his service
agreements, including consultancy and management services, at a rate of £1,000 per day subject to a maximum
of 3 days per calendar month. The appointment can be terminated by either party on three months written
notice.
Letter of Appointment – Helen Pein
Pursuant to a letter of appointment dated 21 September 2021 between the Company and Helen Pein, Helen is
engaged as a Non-Executive Director with fees of £18,000 per annum. In addition Helen Pein will be
remunerated for additional work performed for the Company which is outside the scope of her service
agreements, including project due diligence, consultancy and management services at a rate of £1,000 per day
subject to a maximum of 3 days per calendar month. The appointment can be terminated by either party on
three months written notice.
Letter of Appointment – Vikki Jeckell
Pursuant to a letter of appointment dated 20 November 2023 between the Company and Vikki Jeckell, Vikki is
engaged as a Non-Executive Director with fees of £18,000 per annum. The appointment can be terminated by
either party on three months written notice.
Pursuant to a consultancy agreement dated 21 September 2021 between the Company and Selection Capital
Investments Limited, Paul Atherley is engaged as Key Personnel (as defined under the consultancy agreement)
contracted to provide services to the Company in consideration of payment of £7,000 per month.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
16
Pursuant to a consultancy agreement dated 1 October 2021 between the Company and Lionshead Consultants
Limited (“Lionshead”), a company of which Sam Quinn is a director and sole shareholder, Lionshead is
contracted to provide services to the Company in consideration of payment of £5,000 per month.
Pursuant to a consultancy agreement dated 22 September 2022 between Tees Valley Lithium Limited and
Supply Tactics Limited (“Supply Tactics”), a company of which Vikki Jeckell is a director and 50% shareholder,
Supply Tactics is contracted to provide services to TVL in consideration of payment of £20,000 per month.
Terms of appointment
The services of the Directors are provided under the terms of letters of appointments, as follows:
Director
Year of appointment
Number of periods
completed
Date of current
engagement letter
P Atherley
2021
3
21 September 2021
S Quinn
2021
3
21 September 2021
H Pein
2021
3
21 September 2021
V Jeckell
2023
1
20 November 2023
Consideration of shareholder views
The Board considers shareholder feedback received. This feedback, plus any additional feedback received from
time to time, is considered as part of the Group’s annual policy on remuneration.
Policy for salary reviews
The Group may from time to time seek to review salary levels of Directors, taking into account performance,
time spent in the role and market data for the relevant role. It is intended that there will be a salary review during
the next year as the Company transitions to an operating company.
Policy for new appointments
It is not intended that there will be any new appointments to the Board in the near term. It is intended that a full
review of the Board will take place on an annual basis following the Company’s full transition to an operating
Company following the entering into of the Lease.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
17
Directors’ emoluments and compensation (audited)
Remuneration attributed to the Directors’ during the year ended 31 January 2024 was as follows (all figures are
stated in GBP):
Year Ended 31 January 2024:
Director
Directors fees
Salary/Consulting fees
Total remuneration
P Atherley
31 Jan 2024
59,765
84,000
143,765
S Quinn
31 Jan 2024
44,824
60,000
104,824
H Pein
31 Jan 2024
18,000
-
18,000
V Jeckell
31 Jan 2024
6,000
40,000
46,000
Total
31 Jan 2024
128,589
184,000
312,589
Year Ended 31 January 2023:
Director
Directors fees
Salary/Consulting fees
Total remuneration
P Atherley
31 Jan 2023
24,000
69,000
93,000
S Quinn
31 Jan 2023
18,000
48,600
66,600
H Pein
31 Jan 2023
18,000
-
18,000
Total
31 Jan 2023
60,000
117,600
177,600
Director incentives
In the year ended 31 January 2024, 325,000 options were granted to Directors (2023: 390,000). As at 31
January 2024, 715,000 (2023: 390,000) options issued to Directors were outstanding.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
18
Directors’ Remuneration Policy
Pursuant to the Directors’ letters of appointment, as described above, the Directors receive fees, all payable
monthly in arrears. There is currently a long-term incentive plan in operation for the Directors by way of share
incentive options.
Based on the foregoing, the remuneration policy of the Group can be summarised as follows:
How the element
supports our strategic
objectives
Operation of
the element
Maximum
potential payout
and payment at
threshold
Performance measures used,
weighting and time period applicable
Base Pay
Recognises the role and
the responsibility for the
delivery of strategy and
results
Paid in 12
monthly
instalments
Contractual sum
None
Pensions
None
n/a
n/a
n/a
Short term incentives
None
n/a
n/a
n/a
Long term incentives
Aligns directors and
shareholders in share
price and project
development
Share options
issued
TBC
1/3 of the option vest immediately; 1/3 of
the options vest following the completion
of the fund raising to fund construction
of the first 24,000 tpa capacity at TVL’s
Lithium Hydroxide project at Wilton
International; and 1/3 of the options vest
following commissioning of the first
24,000 tpa capacity at the project.
A remuneration committee is expected to be appointed once the Lease is entered into, to consider an
appropriate level of Directors’ remuneration.
Although there is no formal Director shareholding policy in place, the Board believe that share ownership by
Directors strengthens the link between their personal interests and those of shareholders.
No views were expressed by shareholders during the year on the remuneration policy of the Group.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
19
Other matters
The Group does not currently have any short-term incentive schemes in place for any of the Directors.
The Group does not have any pension plans for any of the Directors and does not pay pension amounts in
relation to their remuneration.
This Directors’ Remuneration Report has been approved by the Board and signed on its behalf by:
Paul Atherley
Non-Executive Chairman
30 May 2024
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
20
Risk Management Report
The Group has undertaken an evaluation of the risks it is exposed to which are summarised as follows:
There is no assurance that the Group will determine that the Project is economically viable and the
Lease may not be entered into
The success of the Group’s business strategy is dependent on its ability to identify sufficient suitable acquisition
opportunities. Whist the Group believes that the Project presents a good opportunity, it is still in the process of
evaluating such opportunity. If the Group fails to complete the development of the Project or enter into the Lease
it may be left with substantial unrecovered transaction costs, potentially including fees, legal costs, accounting
costs, due diligence or other expenses. Furthermore, even if an agreement is reached relating to the Project,
the Group may fail to complete the Project for reasons beyond its control. Any such event will result in a loss to
the Group of the related costs incurred, which could materially adversely affect subsequent attempts to identify
and acquire another target business.
Development and production activities are capital intensive and inherently uncertain in their outcome
and the Group may not make a return on its investments, recover its costs or generate cash flows
The construction of industrial facilities are capital intensive. In addition, environmental damage could greatly
increase the cost of operations, and various operating conditions may adversely and materially affect the levels
of production. These conditions include delays in obtaining governmental approvals or consents, insufficient
storage or transportation capacity or a change in demand for the product. While diligent supervision and
effective maintenance operations can contribute to maximising production rates over time, production delays
and declines from normal operations cannot be eliminated and may adversely and materially affect the
revenues, cash flow, business, results of operations and financial resources and condition of the Company and
its subsidiary undertakings from time to time (the “Group”).
Currently the Group has insufficient capital to meet the funding requirements for the development of
the Project
As the Group is still evaluating the Project, it is still considering the associated costs with the development of
the Project and the amount of additional capital that may be required.
The Group will need to raise additional funding in the near term to meet its working capital requirements for the
next twelve months. In addition to working capital needs, the Group is of the opinion that if it decides to proceed
with the Project, the Group does not have sufficient capital in order to complete the construction of the Project
and hence will be required to raise additional funds in support of project development expenditure requirements.
Based on a high-level preliminary review of expected costs the Directors anticipate that a total of approximately
£250 - 300 million (excluding financing costs) of additional equity and / or debt financing will be required and
subject to the outcome of the feasibility and engineering studies the Group’s confirmation to proceed with the
Project to fund the evaluation, development and construction of the Project. The Group intends to raise the
development costs of the Project by:
(a) Debt finance - Any debt finance in respect of the Group for the purposes of developing and completing the
Project, is likely to be subject to customary conditions precedent. As of the date of this document, the
Group has not yet begun the formal process of seeking third party debt financing in respect of the Project,
however the Group expects to carry out this process immediately following completion of the feasibility
studies and the Group’s confirmation to proceed with the Project.
(b) Equity finance - In relation to any equity financing, the Group expects to engage advisers to assist the
Group with its equity funding requirements. The Group has not yet begun the formal process of seeking
formal engagement with advisers for equity financing in respect of the Project, however the Group expects
to carry out this process in due course following completion of the feasibility and engineering studies.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
21
Based on the Group’s informal discussions with potential debt and equity providers to date, the Directors are
confident that within the period of twelve months following the date of this document the Group will be able to
secure all the necessary finance required to develop and complete the Project.
The failure to secure additional financing or to secure such additional financing on terms acceptable to the
Group could have a material adverse effect on the continued development or growth of the acquired business,
prospects, and the financial condition and results and operations of the Group and could, ultimately lead to the
insolvency of the Company or Group.
The price of lithium hydroxide is affected by factors beyond the Group’s control
If the Group proceeds with the Project, and the market price of lithium hydroxide decreases significantly for an
extended period of time, the ability for the Group to attract finance and ultimately generate profits could be
adversely affected. Numerous external factors and industry factors that are beyond the control of the Group that
affect the price of lithium hydroxide include:
• industrial demand;
• levels of production;
• rapid short term changes in supply and demand because of speculative or hedging activities; and
• global or regional political or economic events.
The price at which the Group can sell any lithium hydroxide it may produce in the future will therefore be relevant
to the future revenues that can be generated by the Group and its ability to finance the Company going forward
and any adverse effects on such price could have a material adverse effect on the Group’s business, financial
performance, results of operations and prospects.
The Group may be unable to hire or retain personnel required to support the Group going forward
The Group’s ability to compete depends upon its ability to retain and attract highly qualified management and
technical personnel. Following completion of the Project, the Group will evaluate the personnel of the acquired
business and may determine that it requires increased support to operate and manage the acquired business
in accordance with the Group’s overall business strategy. There can be no assurance that existing personnel
of the acquired business will be adequate or qualified to carry out the Group’s strategy, or that the Group will
be able to hire or retain experienced, qualified employees to carry out the Group’s strategy.
During the development of the Project, the Group may be unable to acquire or renew necessary
concessions, licenses, permits and other authorisations
The Project will require certain concessions, licences, permits and other authorisations to carry out its
operations. Any delay in obtaining or renewing a license, permit or other authorisation may result in a delay in
investment or development of a resource and may have a materially adverse effect on the acquired business’
results of operations, cash flows and financial condition. In addition, any concessions, licences, permits and
other authorisations of the Project may be suspended, terminated or revoked if it fails to comply with the relevant
requirements.
Failure to obtain (and shortages and disruptions in lead times to deliver) certain key inputs may
adversely affect the Group’s operations during the development of the Project
During the development of the Project, the Group’s inability to timely acquire feedstock, strategic consumables,
raw materials, and processing equipment could have an adverse impact on any results of operations and
financial condition. Periods of high demand for supplies can arise when availability of supplies is limited. This
can cause costs to increase above normal inflation rates. Interruption to supplies or increase in costs could
adversely affect the operating results and cash flows of the Group during the development of the Project.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
22
This Risk Management Report has been approved by the Board and signed on its behalf by:
Paul Atherley
Non-Executive Chairman
30 May 2024
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
23
Corporate Governance Statement
The Group observes the requirements of the Quoted Company Alliance corporate governance code (the “QCA
Code”) and is in compliance with the QCA Code, save as set out below:
1. Given the composition of the Board, certain provisions of the QCA Code are considered by the Board to be
inapplicable to the Company. Specifically, the Company does not consider it necessary to have a senior
independent Director and the Board will, at the outset, consist of three non-executive Directors and one non-
executive chairman.
2. The QCA Code also recommends the submission of Directors for re-election at annual intervals. The
Company Articles of Association require all directors to retire by rotation and seek reappointment by the
shareholders at a general meeting every two years.
In the future, the Directors may seek to transfer from a Standard Listing to either a Premium Listing or other
appropriate stock market (although there can be no guarantee that the Group will fulfil the relevant eligibility
criteria at the time and that a transfer to a Premium Listing or other appropriate stock market will be achieved).
However, in addition to or in lieu of a Premium Listing, the Group may determine to seek a listing on another
stock exchange. Following such a Premium Listing, the Group would comply with the continuing obligations
contained within the Listing Rules and the Disclosure and Transparency Rules in the same manner as any other
group with a Premium Listing.
The Group does not have nomination, remuneration, audit or risk committees. The Board as a whole will instead
review its size, structure and composition, the scale and structure of the Directors’ fees (taking into account the
interests of shareholders and the performance of the Group), take responsibility for the appointment of auditors
and payment of their audit fee, monitor and review the integrity of the Group’s financial statements and take
responsibility for any formal announcements on the Group’s financial performance. Following entry into the
Lease, the Board intends to put in place nomination, remuneration, audit and risk committees.
The Board has a share dealing code that complies with the requirements of the Market Abuse Regulations. All
persons discharging management responsibilities (comprising only the Directors) comply with the share dealing
code.
Carbon emissions
The Group currently has no trade, and two employees other than the Directors and has no office. Therefore,
the Group has minimal carbon emissions and it is not practical to obtain emissions data at this stage.
Board of Directors
The Group has a Board it believes is well suited for the purposes of implementing its business strategy,
combining skill sets for the assessment of investment and acquisition of royalties and streams in the mining
sector.
The Directors are responsible for carrying out the Group’s objectives, implementing its business strategy and
conducting its overall supervision. Acquisition, divestment and other strategic decisions will all be considered
and determined by the Board.
The Board will provide leadership within a framework of prudent and effective controls. The Board will establish
the corporate governance values of the Group and will have overall responsibility for setting the Group’s
strategic aims, defining the business plan and strategy and managing the financial and operational resources
of the Group.
The Board aims to hold meetings on a quarterly basis and is regularly in contact to discuss prospective
acquisition opportunities.
The Articles of the Company contain express provisions relating to conflicts of interest in line with the Companies
Act 2006.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
24
Shareholder communications
The Group uses its corporate website (www.alkemycapital.co.uk) to ensure that the latest announcements,
press releases and published financial information are available to all shareholders and other interested parties.
The AGM is used to communicate with both institutional shareholders and private investors and all shareholders
are encouraged to participate. Separate resolutions are proposed on each issue so that they can be given
proper consideration and there is a resolution to approve the Annual Report and Accounts. Notice of the AGM
is sent to shareholders at least 21 days before the meeting and the results are announced to the London Stock
Exchange and are published on the Company’s website.
Paul Atherley
Non-Executive Chairman
30 May 2024
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
25
Directors’ Responsibility Statement
The Directors are responsible for preparing the Annual Report and the Financial Statements in accordance with
applicable law and regulations.
Company law requires the Directors to prepare Financial Statements for each financial year. Under that law the
Directors have elected to prepare the financial statements in accordance with UK Adopted International
Accounting Standards (“IAS”). Under company law the Directors must not approve the financial statements
unless they are satisfied that they give a true and fair view of the state of affairs of the Group and of the profit
or loss for that period.
In preparing these financial statements, the Directors are required to:
1. select suitable accounting policies and then apply them consistently;
2. make judgements and accounting estimates that are reasonable and prudent;
3. state whether applicable IASs as adopted by the United Kingdom have been followed, subject to any
material departures disclosed and explained in the financial statements; and
4. prepare the financial statements on the going concern basis unless it is inappropriate to presume that
the Company and Group will continue in business.
The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain
the Group’s transactions and disclose with reasonable accuracy at any time the financial position of the Group
and enable them to ensure that the Financial Statements and the Directors Remuneration Report comply with
the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and Group,,
and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
They are also responsible to make a statement that they consider that the Annual Report and Financial
Statements, taken as a whole, is fair, balanced, and understandable and provides the information necessary
for the shareholders to assess the Group’s position and performance, business model and strategy.
The Directors are responsible for the maintenance and integrity of the corporate and financial information
included on the Company’s website. Legislation in the United Kingdom. governing the preparation and
dissemination of the Financial Statements may differ from legislation in other jurisdictions.
Directors’ responsibility statement pursuant to disclosure and Transparency Rule
Each of the Directors, whose names and functions are listed within the Board of Directors confirm that, to the
best of their knowledge:
1. the financial statements are prepared in accordance with International Financial Reporting Standards
(IFRS) as adopted by the United Kingdom, give a true and fair view of the assets, liabilities, financial
position and loss of the Company and Group; and
2. the Annual Report and financial statements, including the Strategic Report, includes a fair review of the
development and performance of the business and the position of the Company and Group, together
with a description of the principal risks and uncertainties that they face.
Approved by the Board on 30 May 2024
Paul Atherley
Non-Executive Chairman
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
26
Independent auditor’s report to the members of Alkemy Capital Investments Plc
Opinion
We have audited the financial statements of Alkemy Capital Investments Plc (the “company”) and its
subsidiaries (the ‘group’) for the year ended 31 January 2024 which comprise consolidated statement of
comprehensive income, consolidated and company statement of financial position, consolidated and company
statement of changes in equity, consolidated and company statement of cash flows, and notes to the financial
statements, including significant accounting policies. The financial reporting framework that has been applied
in the preparation of the group financial statements is applicable law and UK-adopted international accounting
standards.
In our opinion:
• the financial statements give a true and fair view of the state of the group’s and of the company’s affairs
as at 31 January 2024 and of the Group’s loss for the year then ended;
• the financial statements have been properly prepared in accordance with UK-adopted international
accounting standards; and
• the financial statements have been prepared in accordance with the requirements of the Companies Act
2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and
applicable law. Our responsibilities under those standards are further described in the Auditor’s
responsibilities for the audit of the financial statements section of our report. We are independent of the group
and the company in accordance with the ethical requirements that are relevant to our audit of the financial
statements in the UK, including the FRC’s Ethical Standard as applied to listed public interest entities, and we
have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the
audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Material uncertainty related to going concern
We draw attention to the section headed Going Concern at note 2 of the financial statements, which details
factors the Group has considered when assessing the going concern position. As detailed in note 2 the
uncertainty surrounding the availability of funds to finance the commercial development of the group’s projects
indicates the existence of a material uncertainty that may cast significant doubt on the Group’s ability to
continue as a going concern realise its assets and discharge its liabilities in the normal course of business.
Our opinion is not modified in respect of this matter.
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of
accounting in the preparation of the financial statements is appropriate. Our evaluation of the directors’
assessment of the entity’s ability to continue to adopt the going concern basis of accounting included:
• Discussions with management in relation to the future plans of the Group and Company.
• Reviewing activity after the year end to the date of signing the financial statements.
• Reviewing the directors’ going concern assessment including the worst-case scenario cash flow
forecast that covers at least 12 months from the date we expect to sign the audit report.
• Assessing the cash flow requirements of the Group and Company based on forecast capital and
administrative expenditure for 12 months after the date of signing.
• Understanding what forecast expenditure is committed and what could be considered discretionary.
• Considering the liquidity of existing assets of the statement of financial position.
• Considering the options available to management for further fundraising, or additional sources of
finance.
• Considering potential downside scenarios and the resultant impact on funding requirements and the
Company and Group’s ability to raise such funds.
• Considered the likelihood of receipt of fundraising.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
27
• Evaluating the reliability of the data underpinning the forecast cash flows.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the
relevant sections of this report.
Overview of our audit approach
Materiality
In planning and performing our audit we applied the concept of materiality. An item is considered material if it
could reasonably be expected to change the economic decisions of a user of the financial statements. We
used the concept of materiality to both focus our testing and to evaluate the impact of misstatements
identified.
Based on our professional judgement, we determined overall materiality for the financial statements as a
whole to be £100,000 (2023: £125,000), based on 5% of loss before taxation. Materiality for the parent
company financial statements as a whole was set at £46,000 (2023: £28,000) based on approximately 5% of
loss before taxation. We consider this basis of determining materiality to be appropriate for a holding entity of
this nature.
We use a different level of materiality (‘performance materiality’) to determine the extent of our testing for the
audit of the financial statements. Performance materiality is set based on the audit materiality as adjusted for
the judgements made as to the entity risk and our evaluation of the specific risk of each audit area having
regard to the internal control environment. Performance materiality was set at 70% of materiality for the
financial statements as a whole, which equates to £70,000 (2023: £87,500) for the group and £32,200 (2023:
£35,000) for the parent.
Where considered appropriate performance materiality may be reduced to a lower level, such as, for related
party transactions and directors’ remuneration.
We agreed with the Board to report to it all identified errors in excess of £5,000 (2023: £6,250). Errors below
that threshold would also be reported to it if, in our opinion as auditor, disclosure was required on qualitative
grounds.
Overview of the scope of our audit
Our audit was scoped by obtaining an understanding of the group and its environment, including the group’s
system of internal control, and assessing the risks of material misstatement in the financial statements. We also
addressed the risk of management override of internal controls, including assessing whether there was evidence
of bias by the directors that may have represented a risk of material misstatement.
We identified two significant components, being the parent company and its principal operating subsidiary, Tees
Valley Lithium Limited. The base of operations is in the United Kingdom, which is where the head office is. Our
group audit strategy focused on the significant components which were subject to a full scope audit.
The group is accounted for from one central location, the United Kingdom. The audit of the group was performed
by Crowe in the UK. The consolidation was also subject to a full scope audit performed by the Group audit team.
The remaining components of the group were considered non-significant. All balances material to the group
were audited and the remaining balances subject to analytical procedures by the Crowe audit team.
Key Audit Matters
Key audit matters are those matters that, in our professional judgment, were of most significance in our audit
of the financial statements of the current period and include the most significant assessed risks of material
misstatement (whether or not due to fraud) we identified, including those which had the greatest effect on the
overall audit strategy, the allocation of resources in the audit; and directing the efforts of the engagement
team. These matters were addressed in the context of our audit of the financial statements as a whole, and in
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
28
forming our opinion thereon, and we do not provide a separate opinion on these matters. In addition to the
matter described in the material uncertainty related to going concern section, we have determined the matters
described below to be the key audit matters to be communicated in our report.
Key audit matter
How our scope addressed the key audit matter
Capitalisation of intangible assets
The group continues to invest in the
planned construction of LHM refinery in
Wilton International Chemicals Park,
Teeside.
Determining whether the cost of
development meets capitalisation
criteria requires significant judgement
based on the requirements of IAS 38
Intangible Assets.
We therefore consider the inappropriate
capitalisation of development costs to
be a key audit matter. Refer to notes 2
and 10.
We reviewed the accounting policies adopted by
management in relation to the intangible assets and whether
they are consistent with IFRS and meet the criteria as set out
in IAS38, para 31.
We obtained an understanding of the design and
implementation of systems and controls relevant to
impairment assessments of intangibles.
We tested a sample of capitalised invoices to ensure that
these were capital in nature and related to the underlying
asset.
Based on our work performed, we concluded that the
carrying value of the intangible assets is reasonable after
proposed audit adjustments.
Our audit procedures in relation to these matters were designed in the context of our audit opinion as a whole.
They were not designed to enable us to express an opinion on this matter individually and we express no such
opinion.
Other information
The other information comprises the information included in the annual report other than the financial
statements and our auditor’s report thereon. The directors are responsible for the other information contained
within the annual report.
Our opinion on the financial statements does not cover the other information and, except to the extent
otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our
responsibility is to read the other information and, in doing so, consider whether the other information is
materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or
otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material
misstatements, we are required to determine whether this gives rise to a material misstatement in the financial
statements themselves. If, based on the work we have performed, we conclude that there is a material
misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion the part of the directors’ remuneration report to be audited has been properly prepared in
accordance with the Companies Act 2006.
In our opinion based on the work undertaken in the course of our audit:
• the information given in the strategic report and the directors' report for the financial year for which the
financial statements are prepared is consistent with the financial statements; and
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
29
• the directors’ report and strategic report have been prepared in accordance with applicable legal
requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and their environment
obtained in the course of the audit, we have not identified material misstatements in the strategic report or the
directors’ report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006
requires us to report to you if, in our opinion:
• adequate accounting records have not been kept by the group and company, or returns adequate for our
audit have not been received from branches not visited by us; or
• the group and company financial statements and the part of the directors’ remuneration report to be
audited are not in agreement with the accounting records and returns; or
• certain disclosures of directors’ remuneration specified by law are not made; or
• we have not received all the information and explanations we require for our audit.
Responsibilities of the directors for the financial statements
As explained more fully in the directors’ responsibilities statement set out on page 23, the directors are
responsible for the preparation of the financial statements and for being satisfied that they give a true and fair
view, and for such internal control as the directors determine is necessary to enable the preparation of
financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the directors are responsible for assessing the group’s and the parent
company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern
and using the going concern basis of accounting unless the directors either intend to liquidate the group or the
parent company or to cease operations, or have no realistic alternative but to do so.
Auditor’s responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free
from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our
opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in
accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise
from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be
expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design
procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of
irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities,
including fraud is detailed below:
We obtained an understanding of the legal and regulatory frameworks that are applicable to the Group and
company and the procedures in place for ensuring compliance in the jurisdiction where the Group and
company operate, focusing on those laws and regulations that have a direct effect on the determination of
material amounts and disclosures in the financial statements. The laws and regulations we considered in this
context were the Companies Act 2006 and relevant taxation legislation.
We assessed the nature of the group’s business, the control environment and performance to date when
evaluating the incentives and opportunities to commit fraud.
We identified the greatest risk of material impact on the financial statements from irregularities, including
fraud, to be the override of controls by management to manipulate financial reporting and misappropriate
funds. Our procedures to address the risk of management override included:
• enquiries of management about their own identification and assessment of the risks of irregularities;
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
30
• review of the system for the generation, authorisation and posting of journal entries;
• obtaining supporting evidence for a risk-based sample of journals, derived using a data analytics tool;
• audit of significant transactions outside the normal course of business, or those that appear unusual;
• considering audit adjustments identified from our audit work for evidence of bias in reporting;
• considering significant estimates and judgements made by management for evidence of bias, and
performing retrospective reviews where applicable;
• reviewing the other information presented in the annual report for fair representation and consistency with
the audited financial statements and the information available to us as the auditors.
• Review of minutes of board and committee meetings throughout the period and enquiries of management
as to their identification of any non-compliance with laws or regulations, or any or potential claims of fraud;
Owing to the inherent limitations of an audit, there is an unavoidable risk that some material misstatements of
the financial statements may not be detected, even though the audit is properly planned and performed in
accordance with the ISAs (UK). The potential effects of inherent limitations are particularly significant in the
case of misstatement resulting from fraud because fraud may involve sophisticated and carefully organized
schemes designed to conceal it, including deliberate failure to record transactions, collusion or intentional
misrepresentations being made to us.
A further description of our responsibilities for the audit of the financial statements is located on the Financial
Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our
auditor’s report.
Other matters which we are required to address
We were appointed by Board on 27 March 2022 to audit the financial statements for the period ending 31
January 2022. Our total uninterrupted period of engagement is three years, covering the periods ending 31
January 2022 to 31 January 2024.
The non-audit services prohibited by the FRC’s Ethical Standard were not provided to the group or the
company and we remain independent of the group’s and the company in conducting our audit.
Our audit opinion is consistent with the additional report to the Board.
Use of our report
This report is made solely to the Group’s and company's members, as a body, in accordance with Chapter 3
of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the
group’s and company's members those matters we are required to state to them in an auditor's report and for
no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone
other than the group and company and the group’s and company's members as a body, for our audit work, for
this report, or for the opinions we have formed.
Matthew Stallabrass
Senior Statutory Auditor
For and on behalf of
Crowe U.K. LLP
Statutory Auditor
London
30 May 2024
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
31
Consolidated Statement of Comprehensive Income
for the year to 31 January 2024
Year to 31
Year to 31
Notes
January
January
2024
2023
£
£
Continuing operations
Other income
1,247
-
Administrative expenses
4
(1,454,195)
(1,298,002)
Project Development expenses
4
(634,288)
(1,298,011)
Business Development costs
(1,852)
(12,866)
Finance costs
(1,697)
(1,536)
(5,215)
(34,344)
Foreign exchange gains (losses)
Loss before taxation
(2,096,000)
(2,644,759)
7
325,018
-
Taxation
(1,770,982)
(2,644,759)
Loss after taxation
Other Comprehensive Income
Foreign exchange differences on translation of
overseas subsidiaries
(2,306)
(2,645)
Total Comprehensive loss for the year
(1,773,288)
(2,647,404)
Earnings per share:
Basic and diluted earnings per share (pence)
8
(23.43p)
(40.24p)
The notes on pages 38 to 55 are an integral part of these financial statements.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
32
Consolidated Statement of Financial Position
As at 31 January 2024
Notes
31 January
31 January
2024
2023
£
£
Non Current Assets
Intangibles – Project development costs
10
317,089
298,813
Total Non Current Assets
317,089
298,813
Current assets
Trade and other receivables
12
126,303
212,125
Cash and cash equivalents
13
45,458
12,356
Total Current Assets
171,761
224,481
Total Assets
488,850
523,294
Equity
Share Capital
15
176,297
144,000
Share Premium
15
4,261,626
2,413,243
Share Based Payments
15
259,771
63,221
Foreign Exchange Reserve
(4,951)
(2,645)
Retained Earnings
(5,213,391)
(3,442,409)
Total Equity
(520,648)
(824,590)
Current Liabilities
Trade and other payables
14
907,209
1,021,595
Short Term Borrowings
17
102,289
326,289
Current and Total Liabilities
1,009,498
1,347,884
Total Equity and Liabilities
488,850
523,294
The notes on pages 38 to 55 are an integral part of these financial statements.
The financial statements were approved and authorised for issue by the Board on 30 May 2024.
Paul Atherley
Director
Alkemy Capital Investments plc
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
Consolidated Statement of Changes in Equity
For the year ended 31 January 2024
Share
Foreign
Share
Share
Based
Exchange
Retained
capital
Premium
Payments
Reserve
Earnings
Total
£
£
£
£
£
£
As at 1 February 2022
12 0 ,00 0
1,27 9 ,09 4
-
-
(79 7 ,65 0)
60 1 ,44 4
Loss for the year
-
-
-
-
(2,64 4 ,75 9)
(2,64 4 ,75 9)
Foreign exchange losses on
translation of overseas
subsidiaries
-
-
-
(2,64 5)
-
(2,64 5)
Total Comprehensive income
-
-
-
(2,64 5)
(2,64 4 ,75 9)
(2,64 7 ,40 4)
Transactions with owners:
Issue of shares
24 ,00 0
1,13 4 ,14 9
-
-
-
1,15 8 ,149
Issue of options
-
-
63 ,22 1
-
-
63 ,22 1
Total transactions with
owners
24 ,00 0
1,13 4 ,14 9
63 ,22 1
-
-
1,22 1 ,37 0
Balance at 31 January 2023
14 4 ,00 0
2,41 3 ,24 3
63 ,22 1
(2,64 5)
(3,44 2 ,40 9)
(82 4 ,59 0)
Share
Foreign
Share
Share
Based
Exchange
Retained
capital
Premium
Payments
Reserve
Earnings
Total
£
£
£
£
£
£
As at 1 February 2023
14 4 ,00 0
2,41 3 ,24 3
63 ,22 1
(2,64 5)
(3,44 2 ,40 9)
(82 4 ,59 0)
Loss for the year
-
-
-
-
(1,77 0 ,98 2)
(1,77 0 ,98 2)
Foreign exchange losses on
translation of overseas
subsidiaries
-
-
-
(2,30 6)
-
(2,30 6)
Total Comprehensive income
-
-
-
(2,30 6)
(1,77 0 ,98 2)
(1,77 3 ,28 8)
Transactions with owners:
Issue of shares
32 ,29 7
1,84 8 ,38 3
-
-
-
1,88 0 ,68 0
Issue of options
-
-
18 2 ,15 0
-
-
18 2 ,15 0
Issue of warrants
-
-
14 ,40 0
-
-
14 ,40 0
Total transactions with
owners
32 ,29 7
1,84 8 ,38 3
19 6 ,55 0
-
-
2,07 7 ,23 0
Balance at 31 January 2024
17 6 ,29 7
4,26 1 ,62 6
25 9 ,77 1
(4,95 1)
(5,21 3 ,39 1)
(52 0 ,64 8)
The notes on pages 38 to 55 are an integral part of these financial statements.
33
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
34
Consolidated Statement of Cash Flows
for the year ended 31 January 2024
Year to 31
Year to 31
Notes
January
January
2024
2023
£
£
Cash flows from Operating Activities
Loss for the year before tax
(1,770,982)
(2,644,759)
Share based payments
196,550
63,221
Expenditure met directly by funding provider *
-
136,289
Decrease/(Increase) in receivables
12
85,822
(212,052)
(Decrease)/Increase in payables
14
(132,662)
339,705
Net cash outflow from operating activities
(1,621,272)
(2,317,596)
Cashflows from Investing Activities
Payments for intangible assets
10
-
(51,475)
Net cash outflow from investing activities
-
(51,475)
Cash flows from financing activities
Proceeds of borrowing
-
190,000
Repayment of borrowings
(224,000)
-
Issue of shares (net of share issue expenses)
15
1,880,680
1,080,149
1,656,680
1,270,149
Net cash inflow from financing activities
Net increase/(decrease) in cash and cash
equivalents during the year
35,408
(1,098,922)
Cash at the beginning of year
12,356
1,113,923
Effect of foreign exchange on currency holdings
(2,306)
(2,645)
Cash and cash equivalents at the end of the
year
13
45,458
12,356
* During the prior year, expenditure totalling £330,000 (2023: £136,289) was settled directly by Paul Atherley
on behalf of the company against the loan provided by him. As such these amounts represent a material non
cash transaction.
The notes on pages 38 to 55 are an integral part of these financial statements.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
35
Company Statement of Financial Position
As at 31 January 2024
Notes
31 January
2024
31 January
2023
£
£
Non Current Assets
Investments in and loans to subsidiaries
11
2,943,953
1,878,904
Total Non Current Assets
2,943,953
1,878,904
Current assets
Trade and other receivables
12
73,710
83,158
Cash and cash equivalents
13
27,961
5,356
Total Current Assets
101,671
88,514
Total Assets
3,045,624
1,967,418
Equity
Share Capital
15
176,297
144,000
Share Premium
15
4,261,626
2,413,243
Share Based Payments
15
259,771
63,221
Retained Earnings
(2,263,777)
(1,372,013)
Total Equity
2,433,917
1,248,451
Current Liabilities
Trade and other payables
14
509,418
392,678
Short Term Borrowings
102,289
326,289
Current and Total Liabilities
611,707
718,967
Total Equity and Liabilities
3,045,624
1,967,418
Company Statement of Comprehensive Income
As permitted by Section 408 Companies Act 2006, the Company has not presented its own Statement of Comprehensive Income. The
Company’s loss for the financial year was £891,764 (2023: loss of £574,363).
The notes on pages 38 to 55 are an integral part of these financial statements.
The financial statements were approved and authorised for issue by the Board on 30 May 2024.
Paul Atherley
Director
Alkemy Capital Investments plc
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
36
Company Statement of Changes in Equity
For the year ended 31 January 2024
Share
capital
Share
Premium
Share
Based
Payments
Retained
Earnings
Total
£
£
£
£
£
As at 1 February 2022
120,000
1,279,094
-
(797,650)
601,444
Loss for the year
-
-
-
(574,363)
(574,363)
Total Comprehensive
income
-
-
-
(574,363)
(574,363)
Transactions with owners:
Issue of shares
24,000
1,134,149
-
-
1,158 149
Issue of options
-
-
63,221
-
63,221
Total transactions with
owners
24,000
1,134,149
63,221
-
1,221,370
Balance at 31 January 2023
144,000
2,413,243
63,221
(1,372,013)
1,248,451
Share
capital
Share
Premium
Share
Based
Payments
Retained
Earnings
Total
£
£
£
£
£
As at 1 February 2023
144,000
2,413,243
63,221
(1,372,013)
1,248,451
Loss for the year
-
-
-
(891,764)
(891,764)
Total Comprehensive
income
-
-
-
(891,764)
(891,764)
Transactions with owners:
Issue of shares
32,297
1,848,383
-
-
1,880,680
Issue of options
-
-
182,150
-
182,150
Issue of warrants
-
-
14,400
-
14,400
Total transactions with
owners
32,297
1,848,383
196,550
-
2,077,230
Balance at 31 January 2024
176,297
4,261,626
259,771
(2,263,777)
2,433,917
The notes on pages 38 to 55 are an integral part of these financial statements.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
37
Company Statement of Cash Flows
for the year ended 31 January 2024
Notes
Year to 31
January
2024
Year to31
January
2023
£
£
Cash flows from Operating Activities
Loss for the year before tax
(891,764)
(574,363)
Expenditure met directly by funding provider *
-
136,289
Share based payments
196,550
63,221
Decrease/(Increase) in receivables
12
9,448
(83,085)
Increase/(Decrease) in payables
14
116,740
(41,874)
Net cash outflow from operating activities
(569,026)
(499,812)
Cashflows from Investing Activities
Investments in subsidiaries
11
(2)
(2)
Loans provided to subsidiaries
11
(1,065,047)
(1,878,902)
Net cash outflow from investing activities
(1,065,049)
(1,878,904)
Cash flows from financing activities
Proceeds of borrowing
-
190,000
Repayment of borrowings
(224,000)
-
Issue of shares (net of share issue expenses)
15
1,880,680
1,080,149
Net cash inflow from financing activities
1,656,680
1,270,149
Net increase/(decrease) in cash and cash
equivalents during the year
22,605
(1,108,567)
Cash at the beginning of year
5,356
1,113,923
Cash and cash equivalents at the end of the
year
13
27,961
5,356
* During the prior year, expenditure totalling £330,000 (2023: £136,289) was settled directly by Paul Atherley
on behalf of the company against the loan provided by him. As such these amounts represent a material non
cash transaction.
The notes on pages 38 to 55 are an integral part of these financial statements.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
38
Notes to the Financial Statements
1. GENERAL INFORMATION
Alkemy Capital Investments Plc is a company incorporated and domiciled in the United Kingdom. The Company
is a public limited company, which is listed on the London Stock Exchange. The address of the registered office
is 167-169 Great Portland Street, Fifth Floor, London, England W1W 5PF.
The Company was initially formed to undertake an acquisition of a controlling interest in a company or business
in the battery metals sector with the objective of operating the acquired business and implementing an operating
strategy to generate value for its shareholders through operational improvements as well as potentially through
additional complementary acquisitions following the Acquisition.
On 25 February 2022, the Company announced that it had formed a subsidiary called Tees Valley Lithium
Limited (“TVL”) that would aim to develop the UK’s first Lithium Hydroxide processing facility. This transaction
and change of strategy constituted a reverse takeover transaction under the listing rules of the London Stock
Exchange and resulted in Alkemy becoming an operating company.
On 2 May 2022 the Company formed a subsidiary in Australia called Alkemy Capital Services Pty Ltd to act as
a project services company for operations in Australia.
On 22 September 2022 the Company formed a subsidiary in Australia called Port Headland Lithium Pty Ltd to
act as a project holding company for spodumene enrichment operations in Australia.
Group Subsidiaries as at 31 January 2024:
Subsidiary Name
Date
of
Percentage
Registered office address
Country
of
Incorporation
Interest
Incorporation
Tees Valley Lithium Ltd
25
February
100%
167-169 Great Portland Street,
United
2022
London W1W 5PF
Kingdom
Alkemy Capital Services
4 May 2022
100%
Level 4, 46 Colin Street, West
Australia
Pty Ltd
Perth WA 6005, Australia
Port
Headland
Lithium
22 September
100%
Level 4, 46 Colin Street, West
Australia
Pty Ltd
2022
Perth WA 6005, Australia
Tees
Valley
Graphite
20
November
100%
167-169 Great Portland Street,
United
Limited
2023
London W1W 5PF
Kingdom
The financial statements which cover the year to 31 January 2024 are presented in British Pounds Sterling, the
currency of the primary economic environment in which the Company operates. The comparative financial
statements cover the year to 31 January 2023.
2. SUMMARY OF MATERIAL ACCOUNTING POLICIES
The material accounting policies applied in the preparation of these financial statements are set out below. The
policies have been consistently applied throughout the year, unless otherwise stated.
Basis of preparation
The financial statements have been prepared in accordance with UK adopted International Accounting
Standards (“IAS” or “IFRS”), which has been adopted by both the Company and the Group.
The financial statements are presented in pounds sterling (“£”) which is also the functional currency of the
Company.
Going Concern
As part of their assessment of going concern, the Directors have prepared cash forecasts to determine the
funding requirements of the business over the 18 months from the reporting date. Cash requirements over this
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
39
period have been projected in the range of a £2m minimum (decelerated project development case) to £9m
maximum (accelerated project development case) depending on the level of technical project development work
being undertaken, as determined by funding availability.
As at the date of this report, the Directors are considering a variety of funding options from numerous parties to
consider the option best suited to balancing the immediate cash flow needs of the business and desire to
accelerate the project development timeframe against the need to avoid unnecessary dilution of the
shareholders during a period of depressed equity market prices. Options ranging from:
• project level debt or strategic equity which would provide sufficient funding to accelerate the project
development program over the period of consideration, including the Wilton LHM refinery train 1 FEED
study alongside development of the Port Hedland LSM refinery and TVG graphite projects, as well as
general working capital requirements;
• market equity placings to secure working capital funding needs whilst project development funding
opportunities continue to be assessed;
• convertible lending facilities which may act as a hybrid of working capital and project development
funding, allowing progression of project development at a less accelerated rate that would be the case
under a more substantial project lending facility;
• any combination of the above.
The Board remains in detailed discussions on the above funding opportunities and anticipates concluding this
process in the near term.
The Directors are therefore reasonably confident that the necessary funding will be secured, as and when
required, by executing on one of the above options under consideration, such that the Directors have a
reasonable expectation that the Company will continue in operational existence for the next 12 months.
However as successful execution of one of the above fundraising options cannot be assured, a material
uncertainty exists which may cast significant doubt on the ability of the company and group to continue as a
going concern and realise its assets and discharge its liabilities in the normal course of business.
Accordingly, the Directors believe that as at the date of this report it is appropriate to continue to adopt the going
concern basis in preparing the financial statements.
Statement of compliance
The financial statements comply with UK adopted International Accounting Standards (“IAS”).
1. The company has adopted all relevant IASs which were in effect from incorporation when preparing these
financial statements.
2. Standards and Interpretations which are effective in the current year (Changes in accounting policies); None
of the standards which became effective during the year which are applicable to the Company have had a
material impact.
3. Adoption of new Standards and Interpretations to standards in future years; The Directors anticipate that the
adoption of new Standards and Interpretations in future years will have no material impact on the financial
statements of the Company. The Company expects to adopt all relevant Standards and Interpretations as
and when they become effective.
Basis of Consolidation
The consolidated Financial Statements of the Group incorporate the Financial Statements of the Company and
entities controlled by the Company, its subsidiaries, made up to 31 January each year.
Subsidiaries
Subsidiaries are entities over which the Group has the power to govern the financial and operating policies so
as to obtain economic benefits from their activities. Subsidiaries are consolidated from the date on which control
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
40
is obtained, the acquisition date, until the date that control ceases. They are deconsolidated from the date on
which control ceases.
Intra-group transactions, balances and unrealised gains and losses on transactions between Group companies
are eliminated on consolidation, except to the extent that intra-group losses indicate an impairment.
Foreign Currencies
Both the functional and presentational currency of the Company is Sterling (£). Each Group entity determines
its own functional currency and items included in the Financial Statements of each entity are measured using
that functional currency.
The functional currencies of the foreign subsidiaries are the Australian Dollar (“AUD”).
Transactions in currencies other than the functional currency of the relevant entity are initially recorded at the
exchange rate prevailing on the dates of the transaction. At each reporting date, monetary assets and liabilities
that are denominated in foreign currencies are retranslated at the exchange rate prevailing at the reporting date.
Non-monetary assets and liabilities carried at fair value that are denominated in foreign currencies are translated
at the rates prevailing at the date, when the fair value was determined. Gains and losses arising on retranslation
are included in profit or loss for the year, except for exchange differences on non-monetary assets and liabilities,
which are recognised directly in other comprehensive income, when the changes in fair value are recognised
directly in other comprehensive income.
On consolidation, the assets and liabilities of the Group’s overseas operations are translated into the Group’s
presentational currency at exchange rates prevailing at the reporting date. Income and expense items are
translated at the average exchange rates for the year unless exchange rates have fluctuated significantly during
the year, in which case, the exchange rate at the date of the transaction is used. All exchange differences
arising, if any, are recognised as other comprehensive income and are transferred to the Group’s foreign
currency translation reserve. On disposal of any such overseas subsidiaries, cumulative foreign exchange
losses or gains recognised in equity via Other Comprehensive Income become realised and are recognised
through the profit and loss account on disposal.
Taxation
Current taxation is the taxation currently payable on taxable profit for the year.
Current tax is calculated at the tax rates (and laws) that have been enacted or substantively enacted by the
reporting date.
Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of
assets and liabilities in the financial statements and the corresponding tax bases used in the computation of
taxable profit and is accounted for using the balance sheet liability method. Deferred tax liabilities are generally
recognised for all taxable temporary differences and deferred tax assets are recognised to the extent that it is
probable that taxable profits will be available against which deductible temporary differences can be utilised.
Such assets and liabilities are not recognised if the temporary difference arises from the initial recognition of
goodwill or from the initial recognition (other than in a business combination) of other assets and liabilities in a
transaction that affects neither the tax profit nor the accounting profit.
Deferred tax is calculated at the tax rates that are expected to apply in the year when the liability is settled or
the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to
items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred
tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against
current tax liabilities and when they relate to income taxes levied by the same taxation authority and the
Company intends to settle its current tax assets and liabilities on a net basis.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
41
Intangible assets – project development costs
Intangible assets comprise project development costs, incurred on the Group’s Wilton International Chemicals
Park Lithium Hydroxide Monohydrate processing facility in Teesside, UK. These costs include the cost of
obtaining planning permission for the development of the facility, design and planning costs and all technical
and administrative overheads directly associated with this project. These costs are carried forward in the
Statement of Financial Position as non-current intangible assets less provision for identified impairments. Costs
associated with development activity will only be capitalised if they meet the criteria as set out in IAS 38.
Upon any disposal, the difference between the fair value of consideration receivable for development assets
and the relevant cost within non-current assets is recognised in the Income Statement.
Financial assets
Cash and cash equivalents
Cash and cash equivalents comprise cash at hand and current and deposit balances at banks, together with
other short-term, highly liquid investments that are readily convertible into known amounts of cash within a
period of 3 months at inception of the instrument/investment and which are subject to an insignificant risk of
changes in value.
Financial Assets held at amortised costs
The Group classifies its financial assets as held at amortised costs, and consists of trade and other receivables
and loans to subsidiaries (for Company only financial statements).
These assets comprise the types of financial assets, where the objective is to hold these assets in order to
collect contractual cash flows and the contractual cash flows are solely payments of principal and interest. They
are initially recognised at fair value plus transaction costs that are directly attributable to their acquisition or
issue and are subsequently carried at amortised cost, using the effective interest rate method, less provision
for impairment. Impairment provisions for current and non-current trade receivables are recognised, based on
the simplified approach within IFRS 9, using a provision matrix in the determination of the lifetime expected
credit losses. During this process, the probability of the non-payment of the trade receivables is assessed. This
probability is then multiplied by the amount of the expected loss arising from default to determine the lifetime
expected credit loss for the trade receivables. For the receivables, which are reported net, such provisions are
recorded in a separate provision account, with the loss being recognised in the consolidated statement of
comprehensive income. On confirmation that the receivable will not be collectable, the gross carrying value of
the asset is written off against the associated provision.
Impairment provisions, for receivables from related parties and loans to related parties, are recognised based
on a forward-looking expected credit loss model. The methodology used to determine the amount of the
provision is based on whether there has been a significant increase in credit risk since initial recognition of the
financial asset. For those, where the credit risk has not increased significantly since initial recognition of the
financial asset, twelve month expected credit losses along with gross interest income are recognised. For those
for which credit risk has increased significantly, lifetime expected credit losses along with the gross interest
income are recognised. For those that are determined to be credit impaired, lifetime expected credit losses
along with interest income on a net basis are recognised.
The Group’s financial assets measured at amortised cost comprise trade and other receivables and cash and
cash equivalents in the Consolidated Statement of Financial Position. Cash and cash equivalents include cash
in hand, deposits held at call with banks, other short term highly liquid investments with original maturities of
three months or less, and – for the purpose of the statement of cash flows – bank overdrafts. Bank overdrafts
are shown within loans and borrowings in current liabilities on the Consolidated Statement of Financial Position.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
42
Financial liabilities
Financial liabilities are recognised in the statement of financial position when the Group and Company becomes
a party to the contractual provisions of the instrument.
The Company's financial liabilities comprise trade and other payables.
Trade payables are recognised initially at their fair value and subsequently measured at amortised cost.
Equity instruments
An equity instrument is any contract that evidences a residual interest in the assets of the Company after
deducting all of its liabilities. Equity instruments issued by the Company are recorded at the proceeds received
net of direct issue costs.
Ordinary shares are classified as equity.
Share capital account represents the nominal value of the shares issued.
The share premium account represents premiums received on the initial issuing of the share capital. Any
transaction costs associated with the issuing of shares are deducted from share premium, net of any related
income tax benefits.
Retained earnings include all current year results as disclosed in the Statement of Comprehensive Income.
Share-Based Payments
Share Options
The Group operates equity-settled share-based payment arrangements, whereby the fair value of services
provided is determined indirectly by reference to the fair value of the instrument granted.
The fair value of options granted to Directors and others, in respect of services provided, is recognised as an
expense in the Income Statement with a corresponding increase in equity reserves – the share-based payment
reserve.
The fair value is measured at grant date and charged over the vesting period during which the option becomes
unconditional.
The fair value of options is calculated using the Black-Scholes model, taking into account the terms and
conditions upon which the options were granted. The exercise price is fixed at the date of grant.
Non-market conditions are performance conditions that are not related to the market price of the entity’s equity
instruments. They are not considered, when estimating the fair value of a share-based payment. Where the
vesting period is linked to a non-market performance condition, the Group recognises the goods and services
it has acquired during the vesting period, based on the best available estimate of the number of equity
instruments expected to vest. The estimate is reconsidered at each reporting date, based on factors such as a
shortened vesting period, and the cumulative expense is “trued up” for both the change in the number expected
to vest and any change in the expected vesting period.
Market conditions are performance conditions that relate to the market price of the entity’s equity instruments.
These conditions are included in the estimate of the fair value of a share-based payment. They are not taken
into account for the purpose of estimating the number of equity instruments that will vest. Where the vesting
period is linked to a market performance condition, the Group estimates the expected vesting period. If the
actual vesting period is shorter than estimated, the charge is to be accelerated in the period that the entity
delivers the cash or equity instruments to the counterparty. When the vesting period is longer, the expense is
recognised over the originally estimated vesting period.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
43
For other equity instruments, granted during the year (i.e. other than share options), fair value is measured on
the basis of an observable market price.
Critical accounting judgments and estimations
The preparation of the financial statements in conformity with IFRS requires the use of estimates and
assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and
the reported amounts of revenue and expenses during the reporting year. Although these estimates are based
on management’s best knowledge of the amounts, events or actions, actual results ultimately may differ from
these estimates.
Estimates and judgements are continually evaluated and are based on historical experience and other factors,
including expectations of future events that are believed to be reasonable under the circumstances.
The Directors consider the areas of critical accounting judgements or estimations in these financial statements
to be the capitalisation of development expenditure on the Wilton project, vesting periods for share options and
the application of the going concern principal.
On 24 November 2022 the Company received planning permission for the construction of its planned LHM
refinery in Wilton International Chemicals Park, Teeside from the Redcar & Cleveland Borough Council. The
Directors have determined that this event triggers the eligibility for the capitalisation of development expenditure.
Under IAS 38 as the Company now has the commercial and legal rights to construct and exploit the plant for
future economic benefit and, in the judgement of the Directors, the Group retains adequate technical resources
and future availability of necessary financial resources necessary to complete the development of the project.
As such, the costs of obtaining planning permission and all development costs incurred post receipt of planning
permission are recognised as intangible assets in these financial statements. In the event that future events
give rise to circumstances in which the Group no longer holds the commercial rights to develop and explant this
asset, no longer intends to develop this asset or, in the opinion of the directors, the Group is no longer
considered likely to have access to the funding necessary to develop the asset in the future, a material
impairment of this asset would be recognised.
During the year the Company issued a number of share options with market based vesting conditions, notably
when the Company share price reaches a certain threshold. In order to determine the fair value of options as
required under IFRS 2, the Directors have had to make judgements on when these vesting conditions are likely
to be met and the options consequently vest and become exercisable. The judgements have been formed
following analysis of previous Company share price performance to specific events.
See above for further details on the Directors’ assessment that the Company is a going concern.
Impairment of Investments in and loans to Subsidiaries
The carrying amount of investments in and loans made to subsidiaries is tested for impairment annually and
this process is considered to be key judgement along with determining whenever events or changes in
circumstances indicate that the carrying amounts for those assets may not be recoverable. When assessing the
recovery of these balances, the directors consider the likelihood that the subsidiaries will be able to settle
amounts owing, either out of future cashflows or though the recovery of balances receivable or divestment of
assets. Where recovery of these balances is driven by receivable balances within the subsidiary, assessment
of the likelihood of recovery and present value of future cash inflows is undertaken to ensure the amounts
support the subsidiary loan carrying values in full.
No impairment of inter-company loans were deemed necessary in the year.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
44
3. BUSINESS AND GEOGRAPHICAL REPORTING
The accounting policy for identifying segments is based on internal management reporting information that is
regularly reviewed by the chief operating decision maker, which is identified as the Board of Directors. The
Board of Directors consider the Group to have two identifiable operating segments; (a) the construction and
operation of the Wilton Park Lithium Hydroxide processing facility in Teeside, UK and (b) the construction of a
Lithium ore enrichment facility in Port Headland, Australia.
Year to January 2024
UK
Australia
Total
£
£
£
Other Revenue
1,247
-
1,247
Business development
(1,852)
-
(1,852)
Project Development
(349,836)
(284,452)
(634,288)
Administration expenses
(1,295,137)
(159,058)
(1,454,195)
Foreign exchange
(5,215)
-
(5,215)
Finance costs
(1,697)
-
(1,697)
Loss before tax
(1,652,490)
(443,510)
(2,096,000)
4. EXPENSES BY NATURE
2024
2023
£
£
Employee benefit expense (note 6)
302,733
529,782
Employee benefit – share based payments
66,802
53,844
Advertising and Marketing
122,426
147,199
Regulatory compliance expense
67,481
122,324
Legal fees
-
5,584
Share based payments – advisors
115,348
9,377
Travel & accommodation
37,704
81,738
Other professional fees
696,744
267,338
Other operating expenses
44,957
80,816
Total administrative expenses
1,454,195
1,298,002
Project development costs of £634,287 (2023: £1,298,011) in the year comprise the costs incurred in
progressing the Company’s Project in Teesside, U.K and Port Headland, Australia, that do not meet the
criteria for capitalisation into intangible assets.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
45
5. AUDITOR REMUNERATION
During the year the Company obtained the following services from the auditor:
2024
2023
£
£
Fees payable to the auditor for non-audit services
-
-
Fees payable to the auditor for the audit of the Company
47,350
35,276
Total auditor’s remuneration
47,350
35,276
6. EMPLOYEE BENEFIT EXPENSE
2024
2023
£
£
Directors’ salaries
128,589
60,000
Share based payments
182,150
63,221
Staff salaries
145,403
272,051
Recruitment and other staff costs
920
158,451
Social security
27,821
39,280
Total employee benefit expense
484,883
593,003
There were two employees in the year other than the Directors. Further disclosures in respect of Directors’
remuneration are included within the Directors’ Remuneration Report.
7. INCOME TAX
2024
2023
£
£
Loss on ordinary activities before taxation
(2,096,000)
(2,644,759)
Tax calculated at domestic rate applicable to UK standard rate for small
companies of 19%
(398,240)
(502,504)
Effects of:
Expenses not deductible for tax purposes
35,844
12,682
Adjustments relating to tax credits
325,018
-
Tax losses carried forward on which no deferred tax asset is recognised
37,378
489,822
Income tax credit
-
-
2024
2023
£
£
Current tax
-
-
Total
-
-
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
46
Adjustments relating to tax credits in the year arise from research and development tax credits received from
HMRC under its research and development support programme.
Tax losses totalling approximately £3,413,038 (2023: £3,375,660) have been carried forward for use against
future taxable profits. No deferred tax asset has been recognised in respect of these tax losses.
8. EARNINGS PER SHARE
(a) Basic
Basic earnings per share is calculated by dividing the loss attributable to equity holders of the Company by the
weighted average number of ordinary shares in issue during the year.
2024
2023
£
£
Loss from continuing operations attributable to equity holders of the
company
(1,770,982)
(2,644,759)
Weighted average number of ordinary shares in issue
7,560,005
6,572,053
Pence
Pence
Basic and fully diluted loss per share from continuing operations
(23.43)
(40.24)
As at 31 January 2024 and 2023 there were no potentially dilutive instruments in issue for consideration in
arriving at the fully diluted loss per share as the impacts of all such instruments as at the year end are anti-
dilutive.
9. DIVIDENDS
There were no dividends paid or proposed by the Company.
10. INTANGIBLE ASSETS – PROJECT DEVELOPMENT COSTS
2024
2023
£
£
At the beginning of the year
298,813
-
Additions in the year
18,276
298,813
At the end of the year
317,089
298,813
On 24 November 2022 the Group was awarded planning permission by the Redcar & Cleveland Borough
Council for the construction of its planned LHM refinery in Wilton International Chemicals Park, Teeside. In the
view of the directors, this milestone event represents the point when the criteria for capitalisation of project
development costs as outlined in IAS 38 has been met. As a consequence, the Group has commenced the
policy of capitalising all qualifying expenditure from this date. All costs incurred in the year that are directly
associated with the application for and receipt of planning approval have been capitalised, including expenditure
incurred prior to receipt of planning permission.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
47
11. INVESTMENT IN AND LOANS TO SUBSIDIARIES (COMPANY)
2024
2023
£
£
Investment in Subsidiaries
4
2
Loans to Subsidiaries
2,943,949
1,878,902
Total
2,943,953
1,878,904
Loans to subsidiaries have been included within the investment balance due to the long term nature of these
receivables. The loans are interest free and repayable on demand when the subsidiary projects have yielded
economic returns sufficient to settle the value of the loans.
12. TRADE AND OTHER RECEIVABLES
2024
2023
Group
£
£
Prepayments
47,537
45,891
VAT and GST recoverable
73,660
160,165
Other receivables
5,106
6,069
Total
126,303
212,125
2024
2023
Company
£
£
Prepayments
45,490
39,293
VAT and GST recoverable
25,720
39,321
Other receivables
2,500
4,543
Total
73,710
83,157
13. CASH AND CASH EQUIVALENTS
2024
2023
Group
£
£
Cash at bank and on hand
45,458
12,356
45,458
12,356
2024
2023
Company
£
£
Cash at bank and on hand
27,961
5,356
27,961
5,356
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
48
All of the Group’s and Company’s cash and cash equivalents are held in accounts which bear interest at floating
rates and the Directors consider their carrying amount approximates to their fair value. Details of the credit risk
associated with cash and cash equivalents is set out in note 16.
14. TRADE AND OTHER PAYABLES
2024
2023
Group
£
£
Trade payables
673,199
552,146
Other payables
53,965
17,761
Accrued expenses
180,045
451,688
Total trade and other payables
907,209
1,021,595
2024
2023
Company
£
£
Trade payables
364,948
303,250
Other payables
7,365
6,264
Accrued expenses
137,105
83,164
Total trade and other payables
509,418
392,678
Trade payables and accruals principally comprise amounts outstanding for trade purchases and ongoing costs.
The Directors consider that the carrying amount of trade payables approximates to their fair value.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
49
15. SHARE CAPITAL, SHARE PREMIUM & SHARE BASED PAYMENTS
Number of
Share premium
Share based
ordinary shares of
Share Capital
£
payments
2p
£
£
At 31 January 2022
5,999,999
120,000
1,279,094
-
Share issues
1,199,999
24,000
1,175,999
-
Share issue expenses
-
-
(41,850)
-
Issue of Options and
Warrants
-
-
-
63,221
At 31 January 2023
7,199,998
144,000
2,413,243
63,221
Share issues
1,614,853
32,297
1,968,497
-
Share issue expenses
-
-
(105,714)
-
Issue of Options and
Warrants
-
-
(14,400)
196,550
At 31 January 2024
8,814,851
176,297
4,261,626
259,771
Share issues in year and prior year:
On 5 October 2023 the Company issued 964,853 ordinary shares of 2p for cash at a price of £1.40 per share.
On 4 January 2024 the Company issued 650,000 ordinary shares of 2p for cash at a price of £1 per share.
On 9 August 2022 the Company issued 1,199,999 ordinary shares of 2p for cash at a price of £1 per share.
Options issued in the year and prior year:
On 4 August 2022 the Company issued 590,000 options over ordinary shares, exercisable for 5 years from
grant at a strike price of £1 per share and made up of three equal tranches with vesting conditions as follows:
A) The options vest when the Company share price has exceeded £5 for a period of 10 consecutive
trading days;
B) The options vest on the later of i) the share price having exceeded £5 for a period of 10
consecutive trading days and ii) completion of project financing for the construction of the Wilton
Park refinery;
C) The options vest on the later of the share price having exceeded £5 for a period of 10 consecutive
trading days and ii) the commissioning of train 1 of the Wilton Park refinery.
On 5 August 2022 the Company issued 100,000 options over ordinary shares, exercisable for 5 years from
grant at a strike price of £1 per share and made up of three equal tranches with vesting conditions as follows:
A) The options vest when the Company share price has exceeded £5 for a period of 10 consecutive
trading days;
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
50
B) The options vest on the later of i) the share price having exceeded £5 for a period of 10
consecutive trading days and ii) completion of project financing for the construction of the Wilton
Park refinery;
C) The options vest on the later of the share price having exceeded £5 for a period of 10 consecutive
trading days and ii) the commissioning of train 1 of the Wilton Park refinery.
On 19 September 2022 the Company issued 100,000 options over ordinary shares, exercisable for 2 years
from grant at a strike price of £1.5 per share and made up of two tranches with vesting conditions as follows:
A) The options vest when the Company share price has exceeded £5 for a period of 10 consecutive
trading days – 40%;
B) The options vest when the Company share price has exceeded £10 for a period of 10 consecutive
trading days – 60%;
On 6 June 2023 the Company issued 430,000 options over ordinary shares, exercisable for 5 years from
grant at a strike price of £1.75 per share and made up of three equal tranches with vesting conditions as
follows:
A) The options vest when the Company share price has exceeded £5 for a period of 10 consecutive
trading days;
B) The options vest on the later of i) the share price having exceeded £5 for a period of 10
consecutive trading days and ii) completion of project financing for the construction of the Wilton
Park refinery;
C) The options vest on the later of the share price having exceeded £5 for a period of 10 consecutive
trading days and ii) the commissioning of train 1 of the Wilton Park refinery.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
51
D)
The below table provides details on the assumptions used in arriving at the calculation of Fair Value for each
of the above tranches of share options issued in the year and prior year, using the Black Scholes method.
Date of grant
Tranche
Number of
Assumed
Risk free
Volatility (%)
FV
Options
Exercise date
rate (%)
4 August 2022
A
196,668
4 August 2027
1.719
24.51
£59,500
4 August 2022
B
196,667
4 August 2027
1.719
24.51
£59,500
4 August 2022
C
196,665
4 August 2027
1.719
24.51
£59,500
5 August 2022
A
33,334
5 August 2027
1.875
24.49
£9,600
5 August 2022
B
33,333
5 August 2027
1.875
24.49
£9,600
5 August 2022
C
33,333
5 August 2027
1.875
24.49
£9,600
19 September
A
40,000
19 September
3.13
23.77
£2,525
2022
2024
19 September
B
60,000
N/A – lapse prior
3.13
23.77
Nil
2022
to exercise
6 June 2023
A
143,335
6 June 2028
4.39
40.50
£95,150
6 June 2023
B
143,334
6 June 2028
4.39
40.50
£95,149
6 June 2023
C
143,331
6 June 2028
4.39
40.50
£95,147
2024
2023
Company and Group
Number of
options
Number
Weighted
average
exercise
price
£
Number of
options
Number
Weighted
average
exercise
price
Pence
Outstanding at the beginning of the period
790,000
106.33
-
-
Granted during the year
430,000
175
790,000
106.33
Lapsed during the period
-
-
-
-
Outstanding at the end of the period
1,220,000
130.53
790,000
106.33
Share Capital
The share capital account represents the par or nominal value received for ordinary shares issued by the
Company.
Share Premium
The share premium account represents the excess of consideration received for ordinary shares issued above
their nominal value net of transaction costs.
Share-Based Payment Reserve
The share-based payment reserve represents the cumulative fair value charge for options and warrants
granted by the Company over ordinary shares.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
52
Foreign Exchange Reserve
The translation reserve represents the exchange gains and losses that have arisen on the retranslation of
overseas operations.
16. RISK MANAGEMENT OBJECTIVES AND POLICIES
The Group and Company is exposed to a variety of financial risks which result from both its operating and
investing activities. The Group and Company’s risk management is coordinated by the Board of Directors and
focused on actively securing the Group and Company’s short to medium term cash flows by minimising the
exposure to financial markets.
The main risk the Group and Company is exposed to through its financial instruments is credit risk.
Capital risk management
The Group and Company’s objectives when managing capital are:
(a) to safeguard the Group and Company’s ability to continue as a going concern, so that it continues to
provide returns and benefits for shareholders;
(b) to support the Group and Company’s growth; and
(c) to provide capital for the purpose of strengthening the Group and Company’s risk management capability.
The Group and Company actively and regularly reviews and manages its capital structure to ensure an optimal
capital structure and equity holder returns, taking into consideration the future capital requirements of the
Group and Company and capital efficiency, prevailing and projected profitability, projected operating cash
flows, projected capital expenditures and projected strategic investment opportunities. Management regards
total equity as capital and reserves, for capital management purposes. The Group and Company is not subject
to externally imposed capital requirements.
Credit risk
The Group and Company’s financial instruments that are subject to credit risk are cash and cash equivalents.
The credit risk for cash and cash equivalents is considered negligible since the counterparties are reputable
financial institutions.
The Group and Company defines a default by a counterparty to be an event in which a balance receivable
remains unsettled after a period of 90 days from the date on which the balance was due for settlement.
The Group’s maximum exposure to credit risk is £171,761 comprising £126,303 of Trade and other receivables
and £45,458 in cash and cash equivalents. The Company’s maximum exposure to credit risk is £3,045,620
comprising £2,943,949 of intercompany receivables, £73,710 of Trade and other receivables and £27,961 in
cash and cash equivalents.
Liquidity Risk
The Group and Company monitors its rolling cashflow forecasts and liquidity requirements to ensure it has
sufficient cash to meet its operational needs. As the Group and Company maintains its cash reserves in instant
access current accounts liquidity risk to operations is deemed to be minimal. Short term borrowings at the year
end represent a loan provided by Paul Atherley, Group CEO and Directors, which is interest free and repayable
when the Group and Company has raised sufficient additional finance to effect settlement.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
53
Interest Rate Risk
As the Group and Company has no debt, other than the non-interest bearing loan provided by Paul Atherley,
and does not maintain cash reserves on long term deposit accounts liked to interest rates, interest rate risk to
operations is deemed to be minimal.
Foreign Exchange Risk
The Group’s transactions are carried out in a variety of currencies, including Australian Dollars, United Stated
Dollars, Papua New Guinea Kina and UK Sterling. To mitigate the Group’s exposure to foreign currency risk,
non-Sterling cash flows are monitored. Fluctuation of +/- 10% in currencies, other than UK Sterling, would not
have a significant impact on the Group’s net assets or annual results.
The Group does not enter forward exchange contracts to mitigate the exposure to foreign currency risk as
amounts paid and received in specific currencies are expected to largely offset one another.
These assets and liabilities are denominated in the following currencies as shown in the table below:
Group
31 January 2024
GBP
£
AUD
£
Total
£
Intangibles – Project development costs
317,089
-
317,089
Trade and other receivables
90,273
36,030
126,303
Cash and cash equivalents
34,389
11,071
45,460
Trade and other payables
697,889
209,320
907,209
Short-term borrowings
102,289
-
102,289
The Group did not have any material assets or liabilities in any currencies other than GBP as at 31 January
2023.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
54
17. FINANCIAL INSTRUMENTS
Categories of financial instruments:
2024
2023
Group
£
£
FINANCIAL ASSETS AT AMORTISED COST:
Cash and cash equivalents
45,458
12,356
Trade and other receivables
126,303
212,125
Total financial Assets at amortised cost
171,761
224,481
FINANCIAL LIABILITIES AT AMORTISED COST:
Trade and other payables
907,209
1,021,595
Short term borrowings
102,289
326,289
Total financial liabilities at amortised cost
1,009,498
1,347,884
2024
2023
Company
£
£
FINANCIAL ASSETS AT AMORTISED COST:
Cash and cash equivalents
27,961
5,356
Trade and other receivables
73,710
83,158
Total financial Assets at amortised cost
101,671
88,514
2024
2023
£
£
FINANCIAL LIABILITIES AT AMORTISED COST:
Trade and other payables
509,418
392,678
Short term borrowings
102,289
326,289
Total financial liabilities at amortised cost
611,707
718,967
18. RELATED PARTY TRANSACTIONS
The compensation payable to Key Management personnel comprised £312,589 (2023: £177,600) paid by the
Company to the Directors in respect of services to the Company. Full details of the compensation for each
Director are provided in the Directors’ Remuneration Report.
ALKEMY CAPITAL INVESTMENTS PLC (Company number: 13149164)
Financial Report for the year ended 31 January 2024
55
Sam Quinn is a partner in Silvertree Partners LLP who received £65,192 (2023: £55,980) during the year for
the provision of accounting and finance, administration, bookkeeping and secretarial services. At the year end,
an amount of £31,159 (2023: £12,567) was due to Silvertree Partners LLP.
Sam Quinn is a director and shareholder of Lionshead Consultants Ltd who received £60,000 (2023: £48,600)
during the year for the provision of consulting services and £2,093 in reimbursement of expenses (2023:
£5,390). At the year end, an amount of £nil (2023: £13,829) was due to Lionshead Consultants Ltd.
Paul Atherley is a director and shareholder of Selection Capital Ltd who received £84,000 during the year for
the provision of advisory services (2023: £69,000) and £3,172 (2023: £47,852) during the year in reimbursement
of various costs met on behalf of the Company. At the year end, an amount of £108,289 (2023: £16,641) was
due to Selection Capital Ltd.
During the year, Paul Atherley provided a short term working capital loan to the Company, with the balance
outstanding at the reporting date being £102,289 (2023: £326,289). The loan is interest free and repayable
when the Company has raised sufficient additional finance to effect settlement.
During the year, the Group incurred £11,075 (2023: £7,775) in travel related costs and charged £nil (2023:
£3,500) in travel related cost recharges to Pensana plc, a company in which Paul Atherley is a director and
shareholder. As at the reporting date, £18,850 remained outstanding for settlement.
Vikki Jeckel is a director and shareholder of Supply Tactics Ltd who received £40,000 during the year post
appointment for the provision of advisory services (2023: £nil). At the year end, an amount of £72,000 (2023:
£nil) was due to Supply Tactics Ltd.
During the year, the Company provided loans to its two subsidiaries, Tees Valley Lithium Limited (“TVL”) and
Alkemy Capital Services Pty Ltd (“ACSL") by way of funds provided to meet their ongoing cash needs and the
recharging of expenditure met by the Company on behalf of the subsidiaries. Loans provided during the period
totalled £766,866 (2023: £1,776,103) for TVL, £151,670 (2023: £nil) for PHL and £146,487 (2023: £102,801)
for ACSL respectively. Balances remaining owing from subsidiaries to the Company as at 31 January 2023
were £2,542,969 (2023: £1,776,103) for TVL, £151,670 (2023: £nil) for PHL and £249,288 (2023: £102,801) for
ACSL respectively.
During the year, amounts totalling £57,714 (2023: £56,900) were paid to Alex Della Bosca, daughter of Paul
Atherley, for her employment by the Group.
19. POST YEAR-END EVENTS
The Company’s wholly owned subsidiary Tees Valley Graphite, has entered into a non-binding memorandum
of understanding with Syrah Resources Limited for the establishment of a joint venture to develop a
commercial-scale natural graphite active anode material (‘AAM’) processing facility located within the
Teesside Freeport, to supply AAM to the European market.
20. ULTIMATE CONTROLLING PARTY
The Directors consider that the Company has no ultimate controlling party, as no individual member holds more
than 50% of the issued shares.
21. CONTINGENT LIABILITIES AND CAPITAL COMMITMENTS
There were no contingent liabilities or capital commitments as at 31 January 2024 (2023: nil).